image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
064144df0ee904299390d99a9aad93a8114190c3770db04ea6daac6521e95e28.png | complex | <table><tr><td></td><td>ASD</td><td>Control</td></tr><tr><td colspan="3">Saccade error (absolute value in degree of visual angle)</td></tr><tr><td>10 deg</td><td>1.46 (0.43)*</td><td>1.27 (0.07)</td></tr><tr><td>20 deg</td><td>2.40 (0.72)***</td><td>1.86 (0.11)</td></tr><tr><td>30 deg</td><td>3.33 (1.12)**</td><td>2.60... | <table><tr><td></td><td>ASD</td><td>Control</td></tr><tr><td colspan="3">Saccade error (absolute value in degree of visual angle)</td></tr><tr><td>10 deg</td><td>1.46 (0.43)*</td><td>1.27 (0.07)</td></tr><tr><td>20 deg</td><td>2.40 (0.72)***</td><td>1.86 (0.11)</td></tr><tr><td>30 deg</td><td>3.33 (1.12)**</td><td>2.60... | <table><tr><td>30 deg</td><td>313 (55)</td><td>300 (55)</td></tr><tr><td colspan="3">Trial-wise variability (SD) of saccade latency in ms</td></tr><tr><td>10 deg</td><td>80 (30)**</td><td>64 (21)</td></tr><tr><td>20 deg</td><td>90 (37)**</td><td>66 (37)</td></tr><tr><td>30 deg</td><td>90 (32)*</td><td>75 (32)</td></tr>... |
c2b7f7e47f3920a8399a75859ba6da70118be278e73358c6d4387adf1810123c.png | simple | <table><tr><td>Model</td><td>Genotype</td><td>Controls (%)</td><td>Asthma Patients (%)</td><td>OR (95% CI)</td><td>P-value</td></tr><tr><td>rs2280090</td><td>C/C</td><td>166 (83)</td><td>331 (83)</td><td>1</td><td>0.33</td></tr><tr><td></td><td>C/T</td><td>34 (17)</td><td>65 (16.3)</td><td>1.03 (0.61–1.71)</td><t... | <table><tr><td>Model</td><td>Genotype</td><td>Controls (%)</td><td>Asthma Patients (%)</td><td>OR (95% CI)</td><td>P-value</td></tr><tr><td>rs2280090</td><td>C/C</td><td>166 (83)</td><td>331 (83)</td><td>1</td><td>0.33</td></tr><tr><td></td><td>C/T</td><td>34 (17)</td><td>65 (16.3)</td><td>1.03 (0.61–1.71)</td><td></td... | <table><tr><td>87377</td><td></td><td>2 (41)</td><td>)</td><td>1</td><td>0.79</td></tr><tr><td></td><td>G/A</td><td>90 (45)</td><td>197 (49.4)</td><td>1.15 (0.76–1.75)</td><td></td></tr><tr><td></td><td>A/A</td><td>28 (14)</td><td>60 (15)</td><td>1.03 (0.57–1.88)</td><td></td></tr><tr><td>rs511898</td><td>G/G</td><td>9... |
c21198a0a52cf8cd6c99cad77167f161a9af6e03c45fc0228c5ad0f589290caa.png | simple | <table><tr><td>Annotation Clusters</td><td>Official Symbol</td></tr><tr><td>Vascular development</td><td><i>Eph2, Chd7, Ereg, Foxc1, Gja1, Itgav, Lepr, Nus1, Pdpn,Prox1, S1pr1, Socs3, Zfp36l1</i></td></tr><tr><td>Embryonic morphogenesis</td><td><i>Eph2, Chd7, Chst11, Foxc1, Hes1, Il10, Mmp13, Pbx1,Prox1, Socs3, Spry2, ... | <table><tr><td>Annotation Clusters</td><td>Official Symbol</td></tr><tr><td>Vascular development</td><td>Eph2, Chd7, Ereg, Foxc1, Gja1, Itgav, Lepr, Nus1, Pdpn,Prox1, S1pr1, Socs3, Zfp36l1</td></tr><tr><td>Embryonic morphogenesis</td><td>Eph2, Chd7, Chst11, Foxc1, Hes1, Il10, Mmp13, Pbx1,Prox1, Socs3, Spry2, Jag2</td><... | <table><tr><td>Annotation Clusters</td><td>Official Symbol</td></tr><tr><td>Response to wounding, Inflammatory and Defense responses</td><td>Bmp6, Cd14, Calca, Ddah2, Entpd1, Gja1, Hdac5, Il1f6,Il10, Saa1, Saa2, Stat3, Thbd, Thbs1</td></tr><tr><td>Growth factors, GF activity</td><td>Areg, Bmp6, Chst11, Csf3, Ereg, Foxc... |
f98b9111e9799881cb8a869b8ead56191e7fbc4b00fc83aa39e0cb40c00ddad2.png | complex | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Ensembl ID</td><td rowspan="2">Reference</td><td colspan="2">Sites found by RNA-seq for</td><td colspan="2">Sites found by HTA for</td><td rowspan="2">Concordant</td></tr><tr><td>exons</td><td>junctions</td><td>exons</td><td>junctions</td></tr><tr><td>TP63</td><td>ENS... | <table><tr><td rowspan="2">Gene</td><td rowspan="2">Ensembl ID</td><td rowspan="2">Reference</td><td colspan="2">Sites found by RNA-seq for</td><td colspan="2">Sites found by HTA for</td><td rowspan="2">Concordant</td></tr><tr><td>exons</td><td>junctions</td><td>exons</td><td>junctions</td></tr><tr><td>TP63</td><td>ENS... | <table><tr><td>RUNX1</td><td>ENSG00000159216</td><td>Ito et al. [61]</td><td>8</td><td>2</td><td>18</td><td>13</td><td>Yes</td></tr></table> |
6f5321c36af785c761ff536eb9ef648ac81c28e52af239cba30383da83bab638.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Flock size</td><td colspan="2">2000</td><td colspan="2">2010</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td rowspan="4">Flocks enrolled</td><td><26</td><td>1009</td><td>20.4</td><td>547</td><td>15.0</td></tr><tr><td>26–125</td><td>3651</td><td>... | <table><tr><td rowspan="2"></td><td rowspan="2">Flock size</td><td colspan="2">2000</td><td colspan="2">2010</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td rowspan="3">Flocks enrolled</td><td><26</td><td>1009</td><td>20.4</td><td>547</td><td>15.0</td></tr><tr><td>26–125</td><td>3651</td><td>73.9</td>... | <table><tr><td>Flocks enrolled</td><td>>250</td><td>13</td><td>0.3</td><td>54</td><td>1.5</td></tr><tr><td rowspan="4">Ewes enrolled in flocks</td><td><26</td><td>17,044</td><td>6.2</td><td>8355</td><td>3.1</td></tr><tr><td>26–125</td><td>214,086</td><td>77.4</td><td>170,358</td><td>63.1</td></tr><tr><td>126–250</td><t... |
5a12c077b1ca9d7119c805bbd06bdffefdc9191c1f4af21ff7645d1899d7b54e.png | complex | <table><tr><td rowspan="2">Gene</td><td colspan="2">Location</td><td colspan="2">The length of protein(aa)</td></tr><tr><td>SNU8067</td><td>KM91</td><td>SNU8067</td><td>KM91</td></tr><tr><td>1a</td><td>529–12390</td><td>529–12387</td><td>3953</td><td>3952</td></tr><tr><td>1b</td><td>12465–20423</td><t... | <table><tr><td rowspan="2">Gene</td><td colspan="2">Location</td><td colspan="2">The length of protein(aa)</td></tr><tr><td>SNU8067</td><td>KM91</td><td>SNU8067</td><td>KM91</td></tr><tr><td>1a</td><td>529–12390</td><td>529–12387</td><td>3953</td><td>3952</td></tr><tr><td>1b</td><td>12465–20423</td><td>12357–20420</td>... | <table><tr><td>3b</td><td>24056–24250</td><td>23995–24183</td><td>64</td><td>62</td></tr><tr><td>E</td><td>24234–24560</td><td>24167–24496</td><td>108</td><td>109</td></tr><tr><td>M</td><td>24532–25209</td><td>24465–25145</td><td>225</td><td>226</td></tr><tr><td>5a</td><td>25569–25766</td><td>25505–25702</td><td>65</td... |
a9072a7e5eb584a11d953a6541a02226919a9fb8cd54b94e94c467b8b9d2ae4d.png | simple | <table><tr><td>Field</td><td>Code</td><td>Character</td><td>Item amount</td><td>Scores (R)</td><td>Calculation method</td></tr><tr><td>Physical function</td><td>PF</td><td>Function</td><td>5</td><td>3</td><td>(Q1 + Q2 + Q3 + Q4 + Q5)/5</td></tr><tr><td>Role function</td><td>RF</td><td>Function</td><td>2</td><td>3</td><... | <table><tr><td>Field</td><td>Code</td><td>Character</td><td>Item amount</td><td>Scores (R)</td><td>Calculation method</td></tr><tr><td>Physical function</td><td>PF</td><td>Function</td><td>5</td><td>3</td><td>(Q1 + Q2 + Q3 + Q4 + Q5)/5</td></tr><tr><td>Role function</td><td>RF</td><td>Function</td><td>2</td><td>3</td><... | <table><tr><td>Field</td><td>Code</td><td>Character</td><td>Item amount</td><td>Scores (R)</td><td>Calculation method</td></tr><tr><td>ting</td><td>V</td><td>Symptom</td><td></td><td>3</td><td>+ Q15)/2</td></tr><tr><td>Pain</td><td>PA</td><td>Symptom</td><td>2</td><td>3</td><td>(Q9 + Q19)/2</td></tr><tr><td>Dyspnea</td... |
aaa8ae1ce5ed56a6dd025e8630b32e82cfb99d54db27a0fefabcd688c2089e5b.png | simple | <table><tr><td></td><td>PMPs mean (SD) counts/μl</td><td>EMPs-CD31 mean (SD) counts/μl</td><td>EMPs-CD62 mean (SD) counts/μl</td><td>PMPs p <i>vs.</i>Ct</td><td>EMPs-CD31 p <i>vs.</i>Ct</td><td>EMPs-CD62 p <i>vs.</i>Ct</td></tr><tr><td>Control</td><td>15,646 (11,901)</td><td>2,202 (2,784)</td><td>418 (28... | <table><tr><td></td><td>PMPs mean (SD) counts/μl</td><td>EMPs-CD31 mean (SD) counts/μl</td><td>EMPs-CD62 mean (SD) counts/μl</td><td>PMPs p vs.Ct</td><td>EMPs-CD31 p vs.Ct</td><td>EMPs-CD62 p vs.Ct</td></tr><tr><td>Control</td><td>15,646 (11,901)</td><td>2,202 (2,784)</td><td>418 (289)</td><td></td><td></td><td></td></... | <table><tr><td></td><td>PMPs mean (SD) counts/μl</td><td>EMPs-CD31 mean (SD) counts/μl</td><td>EMPs-CD62 mean (SD) counts/μl</td><td>PMPs p vs.Ct</td><td>EMPs-CD31 p vs.Ct</td><td>EMPs-CD62 p vs.Ct</td></tr><tr><td>RRMS</td><td>28,929 (18,247)</td><td>7,136 (6,088)</td><td>511 (231)</td><td><0.001</td><td><0.001</td><t... |
508abbcf0a7aa4ff752ada1e599fb8c1254d0c9e184512595f4f9d1cc7bd6ec7.png | simple | <table><tr><td>Patient</td><td>CA (years)</td><td>BA (years)</td><td>GH peak (ng/mL)</td><td>FT<sub>3</sub> (pmol/L)</td><td>FT<sub>4</sub> (pmol/L)</td><td>TSH (mIU/L)</td><td>TPOAb (IU/mL)</td><td>TgAb (IU/mL)</td><td>IGF-1 (ng/mL)</td><td>PRL (<i>μ</i>g/L)</td><td>Pituitary height (mm)</td></tr><tr><td>1 M</td>... | <table><tr><td>Patient</td><td>CA (years)</td><td>BA (years)</td><td>GH peak (ng/mL)</td><td>FT3 (pmol/L)</td><td>FT4 (pmol/L)</td><td>TSH (mIU/L)</td><td>TPOAb (IU/mL)</td><td>TgAb (IU/mL)</td><td>IGF-1 (ng/mL)</td><td>PRL (μg/L)</td><td>Pituitary height (mm)</td></tr><tr><td>1 M</td><td>6.2</td><td>1.0</td><td>8.0</t... | <table><tr><td>Patient</td><td>CA (years)</td><td>BA (years)</td><td>GH peak (ng/mL)</td><td>FT3 (pmol/L)</td><td>FT4 (pmol/L)</td><td>TSH (mIU/L)</td><td>TPOAb (IU/mL)</td><td>TgAb (IU/mL)</td><td>IGF-1 (ng/mL)</td><td>PRL (μg/L)</td><td>Pituitary height (mm)</td></tr><tr><td>8 M</td><td>15.8</td><td>10.0</td><td>8.0<... |
c545bde3acbe0335930be4ab7f2e01aa09fc54e98a525ba705c6e4a2ae941597.png | complex | <table><tr><td>Primer name</td><td>Assay</td><td>Sequence (5′-3′)</td><td>Exon position</td><td>Target gene</td><td>Amplicon sizes (bp)</td></tr><tr><td>GHRL-1 F</td><td>RT-PCR</td><td>TTTCTGAGCCCTGAACATCAG</td><td>1</td><td><i>GHRL</i></td><td>305 canonical (wild-type) preproghrelin</td></tr><tr><td>GHRL-4... | <table><tr><td>Primer name</td><td>Assay</td><td>Sequence (5′-3′)</td><td>Exon position</td><td>Target gene</td><td>Amplicon sizes (bp)</td></tr><tr><td>GHRL-1 F</td><td>RT-PCR</td><td>TTTCTGAGCCCTGAACATCAG</td><td>1</td><td>GHRL</td><td>305 canonical (wild-type) preproghrelin</td></tr><tr><td>GHRL-4R</td><td></td><td>... | <table><tr><td>GHRL-4R</td><td></td><td>CACGTGGTCTCGGAAGTGT</td><td>4</td><td>GHRL (Δex2 preproghrelin)</td><td>224</td></tr><tr><td>GHRL1_4F</td><td>qRT-PCR</td><td>CTGCAGAAACCCTGGCTGA</td><td>1 / 4</td><td rowspan="2">GHRL (Δex2,3 preproghrelin)</td><td rowspan="2">109</td></tr><tr><td>GHRL-4R</td><td></td><td>CACGTG... |
614814861e95b624795b5bfd23913ec8437491ae6e1462ac7329b14b565c10b0.png | simple | <table><tr><td> </td><td>Case (N = 43)</td><td>Control (N = 179)</td><td><i>p</i></td></tr><tr><td>Primipara</td><td>24 (55.8%)</td><td>75 (41.9%)</td><td>0.14</td></tr><tr><td>Maternal transfer</td><td>28 (65.1%)</td><td>109 (60.9)</td><td>0.742</td></tr><tr><td>Preeclampsia/eclampsia or chronic hypertension</td><td>1... | <table><tr><td></td><td>Case (N = 43)</td><td>Control (N = 179)</td><td>p</td></tr><tr><td>Primipara</td><td>24 (55.8%)</td><td>75 (41.9%)</td><td>0.14</td></tr><tr><td>Maternal transfer</td><td>28 (65.1%)</td><td>109 (60.9)</td><td>0.742</td></tr><tr><td>Preeclampsia/eclampsia or chronic hypertension</td><td>16 (37.2%... | <table><tr><td>Blood transfusion</td><td>21 (48.8%)</td><td>37 (20.7%)</td><td>0.006</td></tr></table> |
2d23b35022e9e31bf4f91298d946ce5d03299aa34ec6b90c01b1d6cf152d3cbb.png | complex | <table><tr><td rowspan="2">Health Variable</td><td colspan="4">Coefficient (Standard Error)</td></tr><tr><td>NR Score</td><td>NR Self</td><td>NR Perspective</td><td>NR Experience</td></tr><tr><td>Depression</td><td>−0.11(0.07)</td><td>−0.02(0.06)</td><td>−0.04(0.06)</td><td>−0.17(0.06) **</td></... | <table><tr><td rowspan="2">Health Variable</td><td colspan="2">Coefficient (Standard Error)</td></tr><tr><td>NR Score</td><td>NR Self</td></tr><tr><td>Depression</td><td>−0.11(0.07)</td><td>−0.02(0.06)</td></tr><tr><td>Anxiety</td><td>−0.08(0.08)</td><td>0.05(0.06)</td></tr><tr><td>Stress</td><td>−0.03(0.07)</td><td>0.... | <table><tr><td colspan="2">Coefficient (Standard Error)</td></tr><tr><td>NR Perspective</td><td>NR Experience</td></tr><tr><td>−0.04(0.06)</td><td>−0.17(0.06) **</td></tr><tr><td>−0.04(0.07)</td><td>−0.17(0.06) **</td></tr><tr><td>0.07(0.06)</td><td>−0.12(0.06) *</td></tr><tr><td>−0.03(0.07)</td><td>0.38(0.06) ***</td>... |
4edc7b8966e486cbaef4fccea84337c96927ca20f4d535cdafe42b8a98e3db5d.png | simple | <table><tr><td>Altitudinal band (m)</td><td>Bryophyte</td><td>Fern</td><td>Seed plants</td><td>Overall plants</td></tr><tr><td>800</td><td>20</td><td>24</td><td>14</td><td>58</td></tr><tr><td>900</td><td>28</td><td>29</td><td>80</td><td>137</td></tr><tr><td>1000</td><td>39</td><td>43</td><td>254</td><td>336</td></tr><t... | <table><tr><td>Altitudinal band (m)</td><td>Bryophyte</td><td>Fern</td><td>Seed plants</td><td>Overall plants</td></tr><tr><td>800</td><td>20</td><td>24</td><td>14</td><td>58</td></tr><tr><td>900</td><td>28</td><td>29</td><td>80</td><td>137</td></tr><tr><td>1000</td><td>39</td><td>43</td><td>254</td><td>336</td></tr><t... | <table><tr><td>Altitudinal band (m)</td><td>Bryophyte</td><td>Fern</td><td>Seed plants</td><td>Overall plants</td></tr><tr><td>2500</td><td>120</td><td>38</td><td>415</td><td>573</td></tr><tr><td>2600</td><td>112</td><td>28</td><td>337</td><td>477</td></tr><tr><td>2700</td><td>115</td><td>29</td><td>304</td><td>448</td... |
92b0e32aa6a1ab82e2b78ff5cd8e0c5479585edf186e8ecfee03611f4f126c31.png | simple | <table><tr><td>Sub-group</td><td>Overall sample</td><td>Bicycle ridership</td></tr><tr><td> </td><td>n=26 078</td><td>n<sup>1</sup>=19 410 (row % 74.4)</td></tr><tr><td> </td><td>Sub-group totals in n (% of n)</td><td>Sub-group totals in n<sup>1 </sup>(% of n<sup>1</sup>)</td></tr><tr><td>Sex:</td><td> </td><td> </td><... | <table><tr><td>Sub-group</td><td>Overall sample</td><td>Bicycle ridership</td></tr><tr><td></td><td>n=26 078</td><td>n1=19 410 (row % 74.4)</td></tr><tr><td></td><td>Sub-group totals in n (% of n)</td><td>Sub-group totals in n1 (% of n1)</td></tr><tr><td>Sex:</td><td></td><td></td></tr><tr><td>Boys</td><td>12 815 (49.2... | <table><tr><td>Sub-group</td><td>Overall sample</td><td>Bicycle ridership</td></tr><tr><td></td><td>n=26 078</td><td>n1=19 410 (row % 74.4)</td></tr><tr><td></td><td>Sub-group totals in n (% of n)</td><td>Sub-group totals in n1 (% of n1)</td></tr><tr><td>Above average</td><td>13 998 (56.9)</td><td>10 817 (58.0) (row % ... |
a45ede39898394866bd6e1a800baaf7ae6ac9a5baa3f717a987be957de713a24.png | simple | <table><tr><td>How did you know when to take your child for his/her most recent immunization?</td><td>ChoseResponse<sup>c </sup>% (95% CI)<sup>d</sup></td><td>UTD4:3:1:3:3 Chose Response % (95% CI)</td><td>UTD4:3:1:3:3 Did Not Chose Response % (95% CI)</td><td>UTD 4:3:1:3:3 Difference % points (95% CI)</td></tr><tr><td... | <table><tr><td>How did you know when to take your child for his/her most recent immunization?</td><td>ChoseResponsec % (95% CI)d</td><td>UTD4:3:1:3:3 Chose Response % (95% CI)</td><td>UTD4:3:1:3:3 Did Not Chose Response % (95% CI)</td><td>UTD 4:3:1:3:3 Difference % points (95% CI)</td></tr><tr><td>Doctor/Nurse at Previ... | <table><tr><td>How did you know when to take your child for his/her most recent immunization?</td><td>ChoseResponsec % (95% CI)d</td><td>UTD4:3:1:3:3 Chose Response % (95% CI)</td><td>UTD4:3:1:3:3 Did Not Chose Response % (95% CI)</td><td>UTD 4:3:1:3:3 Difference % points (95% CI)</td></tr><tr><td>Otherg</td><td>18.3 (... |
7947b27b3f809d473fd3961d69111df75eed47d8fbf3342e62b9131060f66154.png | simple | <table><tr><td> </td><td>CD8<sup>+</sup>T cells</td><td>CD4<sup>+</sup>T cells</td><td>References</td></tr><tr><td>Characteristics</td><td>Decreased HBV-specific CD8<sup>+</sup> T cells; impaired cytotoxicity (IL-2, IFN-<i>γ</i> and TNF-<i>α</i>); increased inhibitory receptors including PD-1, TIM-3, CTLA-4 a... | <table><tr><td></td><td>CD8+T cells</td><td>CD4+T cells</td><td>References</td></tr></table> | <table><tr><td>Characteristics</td><td>Decreased HBV-specific CD8+ T cells; impaired cytotoxicity (IL-2, IFN-γ and TNF-α); increased inhibitory receptors including PD-1, TIM-3, CTLA-4 and 2B4</td><td>Impaired proliferation without obvious defect in Th-1-type cytokines; high PD-1 and low expression of CTLA-4, TIM-3, KLR... |
90ffd2422abec1e988b083181a460fd214056c0d925fef6411adf0a7142cf37e.png | simple | <table><tr><td> </td><td>Mucosal Biopsy</td><td>Surgical Resection</td></tr><tr><td>Actin</td><td>Positive</td><td>Positive</td></tr><tr><td>Vimentin</td><td>Positive</td><td>Positive</td></tr><tr><td>Bcl-2</td><td>Positive</td><td>Positive</td></tr><tr><td>CD138</td><td>Positive</td><td>Not done</td></tr><tr><td>Calpo... | <table><tr><td></td><td>Mucosal Biopsy</td><td>Surgical Resection</td></tr><tr><td>Actin</td><td>Positive</td><td>Positive</td></tr><tr><td>Vimentin</td><td>Positive</td><td>Positive</td></tr><tr><td>Bcl-2</td><td>Positive</td><td>Positive</td></tr><tr><td>CD138</td><td>Positive</td><td>Not done</td></tr><tr><td>Calpon... | <table><tr><td>CK20</td><td>Negative</td><td>Not done</td></tr><tr><td>CD56</td><td>Negative</td><td>Negative</td></tr><tr><td>Desmin</td><td>Negative</td><td>Negative</td></tr><tr><td>S100</td><td>Negative</td><td>Negative</td></tr><tr><td>MPO</td><td>Negative</td><td>Not done</td></tr><tr><td>CD20</td><td>Negative</t... |
6f347459c574ab9b5640bc88941f05ed094825d4fe8918e45fb4607c01a3b545.png | simple | <table><tr><td>Area</td><td>Median</td><td>Range</td><td>Inter Quartile Range (IQR)</td><td>Z*</td><td><i>P </i>value</td></tr><tr><td>Shenzhen (N = 1,826)</td><td>6</td><td>0-8</td><td>4-7</td><td>-12.547</td><td><0.001</td></tr><tr><td>Xiuning (N = 2,572)</td><td>5</td><td>0-8</td><td>3-6</td><td></td><td></td></t... | <table><tr><td>Area</td><td>Median</td><td>Range</td><td>Inter Quartile Range (IQR)</td><td>Z*</td><td>P value</td></tr></table> | <table><tr><td>Shenzhen (N = 1,826)</td><td>6</td><td>0-8</td><td>4-7</td><td>-12.547</td><td><0.001</td></tr><tr><td>Xiuning (N = 2,572)</td><td>5</td><td>0-8</td><td>3-6</td><td></td><td></td></tr></table> |
ab2831a88b4c3d5b8758d388f92e62eca22f626f84a2b7024f3b567b5e1fad19.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Young group</td><td colspan="2">Middle-aged and elderly group</td></tr><tr><td>Men</td><td>Women</td><td>Men</td><td>Women</td></tr><tr><td>Number</td><td>310</td><td>357</td><td>273</td><td>861</td></tr><tr><td>Age (years)</td><td>29 ± 7</td><td>29 ± 7</td><td>... | <table><tr><td></td><td colspan="2">Young group</td><td colspan="2">Middle-aged and elderly group</td></tr></table> | <table><tr><td></td><td>Men</td><td>Women</td><td>Men</td><td>Women</td></tr><tr><td>Number</td><td>310</td><td>357</td><td>273</td><td>861</td></tr><tr><td>Age (years)</td><td>29 ± 7</td><td>29 ± 7</td><td>60 ± 12</td><td>60 ± 11</td></tr><tr><td>Height (cm)</td><td>173.2 ± 5.6</td><td>160.4 ± 5.9</td><td>168.7 ± 6.3<... |
7bc6698baa5d4f2667b85f7356a836049dc43b5bdf3fe0ed611186cc9be576bc.png | simple | <table><tr><td>Cell Line</td><td>MTT Assay</td><td>CellTiter-Glo Assay</td></tr><tr><td>MCF10a</td><td>ND</td><td>ND</td></tr><tr><td>MCF-7</td><td>24±2</td><td>27±2</td></tr><tr><td>T47D</td><td>26±2</td><td>28±3</td></tr><tr><td>MDA-MB-231</td><td>30±3</td><td>30±3</td></tr></table> | <table><tr><td>Cell Line</td><td>MTT Assay</td><td>CellTiter-Glo Assay</td></tr><tr><td>MCF10a</td><td>ND</td><td>ND</td></tr><tr><td>MCF-7</td><td>24±2</td><td>27±2</td></tr><tr><td>T47</td><td>26±</td><td>28</td></tr></table> | <table><tr><td>D</td><td>2</td><td>±3</td></tr><tr><td>MDA-MB-231</td><td>30±3</td><td>30±3</td></tr></table> |
e9f221bc3cbbbbb52da9e4611fdc9c7e1ef83ab291d26edf7e6f3c5ec4fd49ff.png | complex | <table><tr><td>Sno</td><td>Sub-District</td><td>Health Facility</td><td>ANC Attendance</td><td>% of Total Attendance</td><td>Quota Sampled</td></tr><tr><td colspan="6">Wa Municipality</td></tr><tr><td> 1</td><td>Kambale Sub</td><td>Kambale HC</td><td>697</td><td>5.64</td><td>14</td></tr><tr><td> 2</td><td>Bamahu Sub</t... | <table><tr><td>Sno</td><td>Sub-District</td><td>Health Facility</td><td>ANC Attendance</td></tr><tr><td colspan="4">Wa Municipality</td></tr><tr><td>1</td><td>Kambale Sub</td><td>Kambale HC</td><td>697</td></tr><tr><td>2</td><td>Bamahu Sub</td><td>Bamahu HC</td><td>407</td></tr><tr><td>3</td><td>Charingu Sub</td><td>Ch... | <table><tr><td>% of Total Attendance</td><td>Quota Sampled</td></tr><tr><td colspan="2">Wa Municipality</td></tr><tr><td>5.64</td><td>14</td></tr><tr><td>3.30</td><td>8</td></tr><tr><td>2.28</td><td>6</td></tr><tr><td>2.26</td><td>5</td></tr><tr><td>10.87</td><td>180</td></tr><tr><td>72.50</td><td>27</td></tr><tr><td>3... |
2663c865dcb737c38ab27abe34b84611af99d2f9f707374830dbc1412c3b015c.png | simple | <table><tr><td>Biomarker</td><td>Abbreviation</td><td>Biological Sample Type</td><td>Marker Characteristics</td></tr><tr><td>Ethanol</td><td>EtOH</td><td>BloodUrineBreath</td><td>Restricted to conditions where ethanol is still present in circulation.</td></tr><tr><td>Ethyl glucuronide /Ethyl sulfate</td><td>EtG/EtS</td... | <table><tr><td>Biomarker</td><td>Abbreviation</td></tr><tr><td>Ethanol</td><td>EtOH</td></tr><tr><td>Ethyl glucuronide /Ethyl sulfate</td><td>EtG/EtS</td></tr><tr><td>Phosphatidylethanol</td><td>PEth</td></tr><tr><td>Fatty acid ethyl esters</td><td>FAEE</td></tr><tr><td>Acetaldehyde adducts and associated immune respon... | <table><tr><td>Biological Sample Type</td><td>Marker Characteristics</td></tr><tr><td>BloodUrineBreath</td><td>Restricted to conditions where ethanol is still present in circulation.</td></tr><tr><td>UrineSerumCerebrospinal fluidVitreous humourHairNails</td><td>Ethanol metabolite, which remains positive in urine sample... |
6150343a0095a66c6876cf01dab5b42c84732604c384b44039d7bec60b90babc.png | simple | <table><tr><td></td><td>n</td><td>5-year survival rate (%)</td><td><i>P</i> value</td></tr><tr><td>Gender</td><td></td><td></td><td>0.759</td></tr><tr><td> Male</td><td>1102</td><td>52</td><td></td></tr><tr><td> Female</td><td>479</td><td>53</td><td></td></tr><tr><td>Age (yr)</td><td></td><td></td><td>< 0.001</td></... | <table><tr><td></td><td>n</td><td>5-year survival rate (%)</td><td>P value</td></tr><tr><td>Gender</td><td></td><td></td><td>0.759</td></tr></table> | <table><tr><td></td><td>n</td><td>5-year survival rate (%)</td><td>P value</td></tr><tr><td>Male</td><td>1102</td><td>52</td><td></td></tr><tr><td>Female</td><td>479</td><td>53</td><td></td></tr><tr><td>Age (yr)</td><td></td><td></td><td>< 0.001</td></tr><tr><td>≤ 60</td><td>891</td><td>58</td><td></td></tr><tr><td>>60... |
ea4008ec90779c007603324e996addac66da61ff7a76fa0bffd5ab2a7ec94c7b.png | complex | <table><tr><td> </td><td colspan="2">Unstandardized coefficients</td><td>Standardized coefficients</td><td> </td></tr><tr><td>Herbs (g/day)</td><td>Estimate</td><td>Std. error</td><td>Estimate</td><td><i>P </i>value</td></tr><tr><td>Garlic</td><td>0.21</td><td>0.03</td><td>0.08</td><td>0.01</td></tr><tr><td>Cinnamon</t... | <table><tr><td></td><td colspan="2">Unstandardized coefficients</td><td>Standardized coefficients</td><td></td></tr><tr><td>Herbs (g/day)</td><td>Estimate</td><td>Std. error</td><td>Estimate</td><td>P value</td></tr></table> | <table><tr><td>Garlic</td><td>0.21</td><td>0.03</td><td>0.08</td><td>0.01</td></tr><tr><td>Cinnamon</td><td>1.24</td><td>0.19</td><td>0.08</td><td>0.01</td></tr><tr><td>Black pepper</td><td>0.57</td><td>0.15</td><td>0.05</td><td>0.01</td></tr><tr><td>Dried rosemary</td><td>3.43</td><td>1.17</td><td>0.03</td><td>0.01</t... |
7652010d5ea5534f862636115815a32a675b95bc6e9e30c052c1484df9a40b57.png | simple | <table><tr><td> </td><td>Chinese</td><td>Non-Chinese</td><td><i>P</i></td></tr><tr><td>Case-fatality rate, %</td><td> </td><td> </td><td> </td></tr><tr><td>n, all patients</td><td>1,339</td><td>97,939</td><td> </td></tr><tr><td>At 30 days</td><td> </td><td> </td><td> </td></tr><tr><td>Crude, %</td><td>12.3</td><td>10.9... | <table><tr><td></td><td>Chinese</td><td>Non-Chinese</td><td>P</td></tr><tr><td>Case-fatality rate, %</td><td></td><td></td><td></td></tr><tr><td>n, all patients</td><td>1,339</td><td>97,939</td><td></td></tr><tr><td>At 30 days</td><td></td><td></td><td></td></tr><tr><td>Crude, %</td><td>12.3</td><td>10.9</td><td>0.10</... | <table><tr><td></td><td>Chinese</td><td>Non-Chinese</td><td>P</td></tr><tr><td>For HF</td><td></td><td></td><td></td></tr><tr><td>At 30 days</td><td></td><td></td><td></td></tr><tr><td>Crude, %</td><td>5.2</td><td>6.0</td><td>0.23</td></tr><tr><td>Risk-adjusted, % (95% CI)</td><td>5.1 (3.8-6.4)</td><td>6.0 (5.9-6.2)</t... |
33501222b76c94f8129dbf3962974ebef861893cf8c89837034b5ed8877b4285.png | simple | <table><tr><td>Group</td><td>Age (years)</td><td>Gender</td><td>Iris Color*</td><td>BMI (kg/m<sup>2</sup>)</td><td>Carotenoid Intake Score</td><td>Smoking Status</td><td>Years Smoking</td></tr><tr><td>StatinUsers</td><td>58.05 ± 11.08</td><td>n = 13 malesn = 7 females</td><td>2.1 ± 0.9</td><td>27.51 ± 5.... | <table><tr><td>Group</td><td>Age (years)</td><td>Gender</td></tr><tr><td>StatinUsers</td><td>58.05 ± 11.08</td><td>n = 13 malesn = 7 females</td></tr><tr><td>Non-Users</td><td>57.95 ± 11.03</td><td>n = 14 malesn = 6 females</td></tr></table> | <table><tr><td>Iris Color*</td><td>BMI (kg/m2)</td><td>Carotenoid Intake Score</td><td>Smoking Status</td><td>Years Smoking</td></tr><tr><td>2.1 ± 0.9</td><td>27.51 ± 5.19</td><td>14.1 ± 5.25</td><td>n = 13 nonsmokersn = 7 past smokersn = 0 current smokers</td><td>5.3 ± 9.18</td></tr><tr><td>1.9 ± 0.8</td><td>26.34 ± 2... |
8c26d9882e88c66bd677a2137ac04093330ab68793716b17ea2b942b6edfa4e4.png | simple | <table><tr><td>Forecast period</td><td>GMT</td><td>SST</td></tr><tr><td>1 year: 2018</td><td>58%</td><td>75%</td></tr><tr><td>2 years: 2018–2019</td><td>64%</td><td>74%</td></tr><tr><td>3 years: 2018–2020</td><td>70%</td><td>71%</td></tr><tr><td>4 years: 2018–2021</td><td>72%</td><td>69%</td></tr><tr>... | <table><tr><td>Forecast period</td><td>GMT</td><td>SST</td></tr><tr><td>1 year: 2018</td><td>58%</td><td>75%</td></tr><tr><td>2 years: 2018–2019</td><td>64%</td><td>74%</td></tr><tr><td>3 years: 2018–2020</td><td>70%</td><td>71%</td></tr><tr><td>4 years: 2018–2021</td><td>72%</td><td>69%</td></tr></table> | <table><tr><td>5 years: 2018–2022</td><td>58%</td><td>69%</td></tr><tr><td>6 years: 2018–2023</td><td>55%</td><td>65%</td></tr><tr><td>7 years: 2018–2024</td><td>45%</td><td>58%</td></tr><tr><td>8 years: 2018–2025</td><td>50%</td><td>59%</td></tr><tr><td>9 years: 2018–2026</td><td>49%</td><td>60%</td></tr><tr><td>10 ye... |
dea3b502fbe26284d40b25600522838f68b42e4870e180cd3edabcae4f23a197.png | complex | <table><tr><td>Items</td><td>Test-retest reliability ICC (Confident interval)</td><td>Kappa</td><td>Weighted kappa</td><td>Cronbach’s alpha (Dialysis group)</td></tr><tr><td>Symptom/problem</td><td>0.997 (0.991-0.999)</td><td>0.826-1</td><td>0.851-1</td><td>0.833</td></tr><tr><td>Effects of kidney disease</td><td... | <table><tr><td>Items</td><td>Test-retest reliability ICC (Confident interval)</td><td>Kappa</td><td>Weighted kappa</td><td>Cronbach’s alpha (Dialysis group)</td></tr><tr><td>Symptom/problem</td><td>0.997 (0.991-0.999)</td><td>0.826-1</td><td>0.851-1</td><td>0.833</td></tr><tr><td>Effects of kidney disease</td><td>0.983... | <table><tr><td>PCS</td><td>0.993 (0.981-0.998)</td><td rowspan="2">0.688-1</td><td rowspan="2">0.737-1</td><td>0.322</td></tr><tr><td>MCS</td><td>0.996 (0.989-0.999)</td><td>0.537</td></tr></table> |
9ec0ffb7a70dd07a217efd84317a55255de7b71882ba85c755a9a49063a06a60.png | simple | <table><tr><td>GI transit study (<i>n </i>= 11)</td><td>%GE</td><td>GC</td></tr><tr><td><i>Nonseptic animals</i></td><td><i>88.96 ± 8.13</i></td><td><i>4.86 ± 0.45</i></td></tr><tr><td>Sham + vehicle + CLP</td><td>53.27 ± 10.32</td><td>2.53 ± 0.42</td></tr><tr><td>Sham + GTS-21 8 mg/kg + CLP</td><td... | <table><tr><td>GI transit study (n = 11)</td><td>%GE</td></tr><tr><td>Nonseptic animals</td><td>88.96 ± 8.13</td></tr><tr><td>Sham + vehicle + CLP</td><td>53.27 ± 10.32</td></tr><tr><td>Sham + GTS-21 8 mg/kg + CLP</td><td>83.62 ± 5.91*</td></tr><tr><td>SPLX + vehicle + CLP</td><td>79.49 ± 8.98*</td></tr><tr><td>SPLX + ... | <table><tr><td>GC</td></tr><tr><td>4.86 ± 0.45</td></tr><tr><td>2.53 ± 0.42</td></tr><tr><td>4.26 ± 0.35*</td></tr><tr><td>3.86 ± 0.44*</td></tr><tr><td>3.55 ± 0.52</td></tr><tr><td>TNFα</td></tr><tr><td>4.95 ± 0.29</td></tr><tr><td>63.72 ± 21.25</td></tr><tr><td>54.23 ± 25.14</td></tr><tr><td>11.52 ± 1.99#</td></tr><t... |
752f8517e19db45b9c662e6b77d7a8e8167f821e37d8478734cd8555a01cd6c8.png | complex | <table><tr><td colspan="9">Pairs of raters</td></tr><tr><td>PDs</td><td> </td><td colspan="2">Rater TW</td><td>% Agreement</td><td> </td><td colspan="2">Rater NW</td><td>% Agreement</td></tr><tr><td> </td><td>Rater SR</td><td>No (N)</td><td>Yes (Y)</td><td> </td><td>Rater SR</td><td>No (N)</td><td>Yes (Y)</td><td> </td... | <table><tr><td colspan="9">Pairs of raters</td></tr><tr><td>PDs</td><td></td><td colspan="2">Rater TW</td><td>% Agreement</td><td></td><td colspan="2">Rater NW</td><td>% Agreement</td></tr><tr><td></td><td>Rater SR</td><td>No (N)</td><td>Yes (Y)</td><td></td><td>Rater SR</td><td>No (N)</td><td>Yes (Y)</td><td></td></tr... | <table><tr><td colspan="9">Pairs of raters</td></tr><tr><td></td><td>Y</td><td>1</td><td>0</td><td></td><td>Y</td><td>0</td><td>0</td><td></td></tr><tr><td>Schizotypal</td><td>N</td><td>9</td><td>0</td><td>100</td><td>N</td><td>8</td><td>0</td><td>100</td></tr><tr><td></td><td>Y</td><td>0</td><td>1</td><td></td><td>Y</... |
c384a926ef4cee2ef1149791463f291bb887304c5af7e5fae5b8e58b7bd63c41.png | simple | <table><tr><td>Rank</td><td>Journal</td><td># citations</td></tr><tr><td>1</td><td><i>Journal of the American Chemical Society</i></td><td>351</td></tr><tr><td>2</td><td><i>Journal of Organic Chemistry</i></td><td>65</td></tr><tr><td>3</td><td><i>Journal of Physical Chemistry A</i></td><td>64</td></tr><tr><td>4</td><td... | <table><tr><td>Rank</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>8</td></tr><tr><td>10</td></tr></table> | <table><tr><td>Journal</td><td># citations</td></tr><tr><td>Journal of the American Chemical Society</td><td>351</td></tr><tr><td>Journal of Organic Chemistry</td><td>65</td></tr><tr><td>Journal of Physical Chemistry A</td><td>64</td></tr><tr><td>Journal of Chemical Physics</td><td>58</td></tr><tr><td>Angewandte Chemie... |
79c1135be997b94fd14d3bde0ea919dd2ccaddc4f0da04da256b95b030070ba0.png | complex | <table><tr><td>Study (Author-Date)</td><td>Representativeness</td><td>Demonstration that outcome not present at outset</td><td>Assessment of outcome (proven infection vs suspected infection based on other criteria)</td><td>Adequacy of follow-up (<5% loss)</td></tr><tr><td>Alleyne 2000 [31]</td><td>*</td><td>*</td><t... | <table><tr><td>Study (Author-Date)</td><td>Representativeness</td><td>Demonstration that outcome not present at outset</td><td>Assessment of outcome (proven infection vs suspected infection based on other criteria)</td><td>Adequacy of follow-up (<5% loss)</td></tr><tr><td>Alleyne 2000 [31]</td><td>*</td><td>*</td><td>*... | <table><tr><td>Study (Author-Date)</td><td>Representativeness</td><td>Demonstration that outcome not present at outset</td><td>Assessment of outcome (proven infection vs suspected infection based on other criteria)</td><td>Adequacy of follow-up (<5% loss)</td></tr><tr><td>Kitchen 2011 [6]</td><td></td><td></td><td>*</t... |
b58cdd9628fbb25822c478a385a5aed62551808613179b0fefd336ea46544246.png | complex | <table><tr><td colspan="3">EU Rarotonga</td><td colspan="3">EU southern group</td><td colspan="3">EU northern group</td></tr><tr><td>Village surveyed</td><td>No. of people surveyed</td><td>% Ag positive</td><td>Island surveyed</td><td>No. of people surveyed</td><td>% Ag positive</td><td>Island surveyed</td><td>No. of p... | <table><tr><td colspan="3">EU Rarotonga</td><td colspan="3">EU southern group</td><td colspan="3">EU northern group</td></tr><tr><td>Village surveyed</td><td>No. of people surveyed</td><td>% Ag positive</td><td>Island surveyed</td><td>No. of people surveyed</td><td>% Ag positive</td><td>Island surveyed</td><td>No. of p... | <table><tr><td>Ruatonga/A Vaitu</td><td>200</td><td>0.50</td><td>Mauke</td><td>150</td><td>0.00</td><td>Manihiki</td><td>100</td><td>0.00</td></tr><tr><td>Pokoinu/Nikao</td><td>200</td><td>0.00</td><td>Mangaia</td><td>200</td><td>0.50</td><td>Rakahanga</td><td>100</td><td>2.00</td></tr><tr><td>Takitumu</td><td>200</td>... |
2f2d85fb82a0d519ab6fa48ba4c2aa8b71524d4c99c7aa01c433c7c75f6819e7.png | complex | <table><tr><td></td><td colspan="2">HIV-2 infected</td><td colspan="2">HIV-uninfected</td><td></td></tr><tr><td></td><td>Number died/total per category (%)</td><td>Mortality rate per 100 person-years (95% CI)</td><td>Number died/total per category (%)</td><td>Mortality rate per 100 person-years (95% CI)</td><td>Rate ra... | <table><tr><td></td><td colspan="2">HIV-2 infected</td><td colspan="2">HIV-uninfected</td><td></td></tr><tr><td></td><td>Number died/total per category (%)</td><td>Mortality rate per 100 person-years (95% CI)</td><td>Number died/total per category (%)</td><td>Mortality rate per 100 person-years (95% CI)</td><td>Rate ra... | <table><tr><td>Age groupa, b</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><40</td><td>15/37 (41)</td><td>3.4 (2.0, 5.6)</td><td>7/56 (13)</td><td>0.8 (0.4, 1.7)</td><td>4.2 (1.7, 10.2)</td></tr><tr><td>40-59</td><td>23/59 (39)</td><td>3.4 (2.3, 5.1)</td><td>15/63 (24)</td><td>1.6 (1.0, 2.7)</td><td>2.1... |
4bcac2e83761daf1d1a11849a0de158c132917631b955c9442a86883d02826ea.png | complex | <table><tr><td>Group</td><td>Null model</td><td>Full model (OR < 95 % CI)</td></tr><tr><td colspan="3">Individual</td></tr><tr><td colspan="3"> Gender</td></tr><tr><td>Male</td><td></td><td>1.00</td></tr><tr><td>Female</td><td></td><td><i>0.45 (0.23, 0.88)**</i></td></tr><tr><td colspan="3"> Education</td></tr><tr><... | <table><tr><td>Group</td><td>Null model</td><td>Full model (OR < 95 % CI)</td></tr><tr><td colspan="3">Individual</td></tr></table> | <table><tr><td>Group</td><td>Null model</td><td>Full model (OR < 95 % CI)</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Male</td><td></td><td>1.00</td></tr><tr><td>Female</td><td></td><td>0.45 (0.23, 0.88)**</td></tr><tr><td colspan="3">Education</td></tr><tr><td>Elementary school or less</td><td></td><td>1.00</... |
7fd6b063d9dfb1b55cc01dde0939965dc3325149ddfd3d252d2e5406f056e4dd.png | simple | <table><tr><td>Gene<sup>a</sup></td><td><i>Oedogonium</i></td><td><i>Stigeoclonium</i></td><td><i>Scenedesmus</i></td><td><i>Chlamydomonas</i></td></tr><tr><td><i>infA</i></td><td>+</td><td>-</td><td>+</td><td>-</td></tr><tr><td><i>petA</i></td><td>-</td><td>-</td><td>+</td><td>+</td></tr><tr><td><i>psaM</i></td><td>+<... | <table><tr><td>Genea</td><td>Oedogonium</td><td>Stigeoclonium</td><td>Scenedesmus</td><td>Chlamydomonas</td></tr><tr><td>infA</td><td>+</td><td>-</td><td>+</td><td>-</td></tr><tr><td>petA</td><td>-</td><td>-</td><td>+</td><td>+</td></tr><tr><td>psaM</td><td>+</td><td>+</td><td>-</td><td>-</td></tr><tr><td>rpl12</td><td... | <table><tr><td>trnL(caa)</td><td>+</td><td>+</td><td>-</td><td>-</td></tr><tr><td>trnR(ccu)</td><td>+</td><td>-</td><td>-</td><td>-</td></tr><tr><td>trnR(ucg)</td><td>+</td><td>-</td><td>-</td><td>-</td></tr><tr><td>trnS(gga)</td><td>-</td><td>+</td><td>-</td><td>-</td></tr></table> |
5ae2e9aa532279b4f1097fed8b820409c4d6f4cd17d96e9b538507545fc7f631.png | complex | <table><tr><td colspan="2">Set A</td><td colspan="2">Set B</td><td></td></tr><tr><td>CV</td><td>AoA</td><td>CV</td><td>AoA</td><td></td></tr><tr><td>CHAT</td><td>3.80</td><td>PIED</td><td>3.60</td><td><i>Children + Adults</i></td></tr><tr><td>OEIL</td><td>4.10</td><td>RUE</td><td>5.20</td><td><i>Children + Adults</i></... | <table><tr><td colspan="2">Set A</td><td>Set B</td></tr><tr><td>CV</td><td>AoA</td><td>CV</td></tr><tr><td>CHAT</td><td>3.80</td><td>PIED</td></tr><tr><td>OEIL</td><td>4.10</td><td>RUE</td></tr><tr><td>OEUF</td><td>4.50</td><td>BOUE</td></tr><tr><td>BEAU</td><td>4.50</td><td>PLUIE</td></tr><tr><td>DOUX</td><td>5.10</td... | <table><tr><td>Set B</td><td></td></tr><tr><td>AoA</td><td></td></tr><tr><td>3.60</td><td>Children + Adults</td></tr><tr><td>5.20</td><td>Children + Adults</td></tr><tr><td>5.80</td><td>Children + Adults</td></tr><tr><td>4.40</td><td>Children + Adults</td></tr><tr><td>5.60</td><td>Children + Adults</td></tr><tr><td>4.7... |
7a24e2fbd29b2e618fcd1ffa24d5b622cfe9a46a85cfb890517c789b23bfc5da.png | simple | <table><tr><td></td><td><i>Relapse group (n=30)</i></td><td><i>Remission group (n=35)</i></td><td><i>P</i></td></tr><tr><td>Withdrawal MPV (fL)</td><td>8.0±1.2</td><td>8.0±1.0</td><td>0.81</td></tr><tr><td>Withdrawal TSH (uIU/ml)</td><td>1.5±1.0</td><td>2.0±1.0</td><td>0.03</td></tr><tr><td>Withdraw... | <table><tr><td></td><td>Relapse group (n=30)</td><td>Remission group (n=35)</td><td>P</td></tr></table> | <table><tr><td>Withdrawal MPV (fL)</td><td>8.0±1.2</td><td>8.0±1.0</td><td>0.81</td></tr><tr><td>Withdrawal TSH (uIU/ml)</td><td>1.5±1.0</td><td>2.0±1.0</td><td>0.03</td></tr><tr><td>Withdrawal fT3 (pmol/L)</td><td>4.8±1.2</td><td>4.7±0.5</td><td>0.46</td></tr><tr><td>Withdrawal fT4 (pmol/L)</td><td>14.8±2.9</td><td>13... |
8d315da87b1bc1970f5c51a19a611d9a581de20ee31221aa5e93e1a62c8f3060.png | simple | <table><tr><td>Isolates</td><td>Identification by API system (% similarity)</td><td>Identification by rep-PCR (% identity)</td></tr><tr><td>1S</td><td><i>Lactobacillus plantarum (99.9%)</i></td><td><i>Lactobacillus plantarum (72.5%)</i></td></tr><tr><td>2S</td><td><i>Lactobacillus plantarum (99.9%)</i></td><td><i>Lacto... | <table><tr><td>Isolates</td><td>Identification by API system (% similarity)</td><td>Identification by rep-PCR (% identity)</td></tr><tr><td>1S</td><td>Lactobacillus plantarum (99.9%)</td><td>Lactobacillus plantarum (72.5%)</td></tr><tr><td>2S</td><td>Lactobacillus plantarum (99.9%)</td><td>Lactobacillus plantarum (80.0... | <table><tr><td>13S*</td><td>Lactobacillus coprophilus (77.0%)</td><td>Lactobacillus fermentum (68.4%)</td></tr><tr><td>1SB1</td><td>Lactobacillus coprophilus (97.0%)</td><td>unidentified</td></tr></table> |
9d37acdee2c965cf4e391817715e7bd3827b0e52e54cd2fea0a71940619b8a62.png | simple | <table><tr><td></td><td>Risk of T2D</td><td>Prediabetes</td><td>HOMA-IR</td></tr><tr><td>Highest ρ<sub>E</sub></td><td>Cer(d18:0/24:1),0.3177, <i>p</i> = 2.7 × 10<sup>−8</sup></td><td>PS(40:5),0.2917, <i>p</i> = 1.0000</td><td>Cer(d18:0/22:0), 0.4234, <i>p</i> = 2.3 × 10<sup>−24</sup></td></t... | <table><tr><td></td><td>Risk of T2D</td><td>Prediabetes</td><td>HOMA-IR</td></tr><tr><td>Highest ρE</td><td>Cer(d18:0/24:1),0.3177, p = 2.7 × 10−8</td><td>PS(40:5),0.2917, p = 1.0000</td><td>Cer(d18:0/22:0), 0.4234, p = 2.3 × 10−24</td></tr></table> | <table><tr><td>Lowest ρE</td><td>LPC(26:0),−0.3588 p = 0.0001</td><td>PC(39:6),−0.2076, p = 0.1501</td><td>PC(P-34:1),−0.2972, p = 7.8 × 10−17</td></tr><tr><td>N (significant)</td><td>114</td><td>59</td><td>172</td></tr></table> |
24f495dfd9f66a3e3ac1faf563655a3487ee74a6e6a9c81781927c86737423a7.png | simple | <table><tr><td>Gene symbol</td><td>Forward primer (5′ to 3′)</td><td>Reverse primer (5′ to 3′)</td></tr><tr><td>Oct-4</td><td>CTTGGGCTACACAGGC</td><td>CTCAATACTCGTTCGCTTTC</td></tr><tr><td>Nanog</td><td>TTTGGAAGCTGCTGGGGAAG</td><td>GATGGGAGGAGGGGAGAGGA</td></tr><tr><td>CDX2</td><td>CCGAACAGGGACT... | <table><tr><td>Gene symbol</td><td>Forward primer (5′ to 3′)</td></tr><tr><td>Oct-4</td><td>CTTGGGCTACACAGGC</td></tr><tr><td>Nanog</td><td>TTTGGAAGCTGCTGGGGAAG</td></tr><tr><td>CDX2</td><td>CCGAACAGGGACTTGTTTAGAG</td></tr><tr><td>TF</td><td>ACGCTCCTGCTCGGCTGGGT</td></tr><tr><td>GAPDH</td><td>GGAGCCAAAAGGGTCATC</td></t... | <table><tr><td>Reverse primer (5′ to 3′)</td></tr><tr><td>CTCAATACTCGTTCGCTTTC</td></tr><tr><td>GATGGGAGGAGGGGAGAGGA</td></tr><tr><td>CTCTGGCTTGGATGTTACACAG</td></tr><tr><td>CGTCTGCTTCACATCCTTCA</td></tr><tr><td>CCAGTGAGTTTCCCGTTC</td></tr></table> |
587e6057f192792b9886d621c5369dc90da9e709e70b7e8ecaf82df1b91e7474.png | simple | <table><tr><td></td><td>Mouse strain</td><td>Methods</td><td>PV cells with PNNs (%)</td></tr><tr><td>Visual cortex</td><td></td><td></td><td></td></tr><tr><td> Pizzo et al., 2016</td><td>C57BL/6J</td><td>PV: (1) monoclonal mouse α-PV (SWANT, 1:500); (2) polyclonal guinea pig α-PV PNN: biotin-conjugated WFA (S... | <table><tr><td></td><td>Mouse strain</td><td>Methods</td><td>PV cells with PNNs (%)</td></tr><tr><td>Visual cortex</td><td></td><td></td><td></td></tr><tr><td>Pizzo et al., 2016</td><td>C57BL/6J</td><td>PV: (1) monoclonal mouse α-PV (SWANT, 1:500); (2) polyclonal guinea pig α-PV PNN: biotin-conjugated WFA (Sigma, 1:200... | <table><tr><td></td><td>Mouse strain</td><td>Methods</td><td>PV cells with PNNs (%)</td></tr><tr><td>Ueno et al., 2017b</td><td>C57BL/6J</td><td>PV: monoclonal mouse α-PV (Sigma, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:200)</td><td>Layer 2-3 P14: ∼70%; P21, 28: ∼50% P56: ∼60% Layer 4 P14, 21, 28: ∼75% P56: ∼90% L... |
8cc23150ba81a6a3d61e3abb5473bab415695e0ab4f810a45303f46106547d47.png | complex | <table><tr><td></td><td colspan="4">Normal weight mice</td><td colspan="4">DIO mice</td></tr><tr><td></td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td></tr><tr><td>Ghrelin (pg/ml)</td><td>114.1 ± 27.9</td><td>186.9 ± 14.8</td><td>361.3 ± 79.9</... | <table><tr><td></td><td colspan="4">Normal weight mice</td><td colspan="4">DIO mice</td></tr><tr><td></td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td></tr><tr><td>Ghrelin (pg/ml)</td><td>114.1 ± 27.9</td><td>186.9 ± 14.8</td><td>361.3 ± 79.9</td><td>p=0.009<... | <table><tr><td></td><td colspan="4">Normal weight mice</td><td colspan="4">DIO mice</td></tr><tr><td></td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td><td>PBS</td><td>NS1</td><td>Vaccine</td><td>Sig.</td></tr><tr><td>TNF-α</td><td>0.30 ± 0.30</td><td>8.42 ± 4.22</td><td>1.65 ± 1.31</td><td>NS</td><td>45.59 ± 24... |
a623929f4b6014f85456200c29a782f8f48a36ee9042c648fc1f593f9f048c44.png | simple | <table><tr><td>Authors</td><td>Novel prognostic marker</td><td>Conclusion</td></tr><tr><td>Li et al. 2015 [39]</td><td>The expression patterns of miR-15a/16-1</td><td>miR-15a seems to be linked with disease progression and prognosis while miR-16-1 acts as a valuable diagnostic marker</td></tr><tr><td> Wang et al. 2015 ... | <table><tr><td>Authors</td><td>Novel prognostic marker</td><td>Conclusion</td></tr><tr><td>Li et al. 2015 [39]</td><td>The expression patterns of miR-15a/16-1</td><td>miR-15a seems to be linked with disease progression and prognosis while miR-16-1 acts as a valuable diagnostic marker</td></tr><tr><td>Wang et al. 2015 [... | <table><tr><td>Lullo et al. 2015 [45]</td><td>Th22 cells</td><td>Increased frequency of IL-22(+)IL-17(−)IL-13(+) T cells correlates with poor prognosis</td></tr><tr><td>Li et al. 2015 [46]</td><td>Downregulated miR-33b</td><td>miR-33b low expression had significantly shortened PFS and OS</td></tr><tr><td>Bolomsky et al... |
813ecd0b048483ce7b2ef2b7cf733d0d5dea603a67c37543640bafc7ee95421f.png | simple | <table><tr><td>SYMBOL</td><td>RefSeq</td><td>logFC</td><td>adj.P.Val</td><td>Sens.</td><td>Spec.</td><td>KEGGID</td></tr><tr><td>SERPINA1</td><td>NM_000295, NM_001002235, NM_001002236</td><td>3.30</td><td>7.81e-39</td><td>0.98</td><td>1.00</td><td>04610</td></tr><tr><td>PROS1</td><td>NM_000313</td><td>2.12</td><td>8.89... | <table><tr><td>SYMBOL</td><td>RefSeq</td><td>logFC</td><td>adj.P.Val</td><td>Sens.</td><td>Spec.</td><td>KEGGID</td></tr><tr><td>SERPINA1</td><td>NM_000295, NM_001002235, NM_001002236</td><td>3.30</td><td>7.81e-39</td><td>0.98</td><td>1.00</td><td>04610</td></tr><tr><td>PROS1</td><td>NM_000313</td><td>2.12</td><td>8.89... | <table><tr><td>PDLIM4</td><td>NM_003687</td><td>2.21</td><td>3.37e-26</td><td>0.96</td><td>0.98</td><td>NA</td></tr><tr><td>KRT19</td><td>NM_002276</td><td>2.33</td><td>3.40e-25</td><td>0.98</td><td>0.98</td><td>NA</td></tr><tr><td>CITED1</td><td>NM_004143</td><td>3.17</td><td>4.42e-25</td><td>0.94</td><td>0.96</td><td... |
e71bdc256e7b416f442f5e5256988e1739ef72e93e6b9d8ce4e9b87bd6868ce0.png | complex | <table><tr><td></td><td colspan="2">Subjects</td></tr><tr><td></td><td><i>Number</i></td><td><i>Percentage</i></td></tr><tr><td>Supplements use</td><td></td><td></td></tr><tr><td>No</td><td>145</td><td>69.9%</td></tr><tr><td>Yes</td><td>62</td><td>30.1%</td></tr><tr><td>Users of supplement by gender</td><td></td><td></... | <table><tr><td></td><td>Subjects</td></tr><tr><td></td><td>Number</td></tr><tr><td>Supplements use</td><td></td></tr><tr><td>No</td><td>145</td></tr><tr><td>Yes</td><td>62</td></tr><tr><td>Users of supplement by gender</td><td></td></tr><tr><td>Male</td><td>43</td></tr><tr><td>Female</td><td>19</td></tr><tr><td>Frequen... | <table><tr><td>Subjects</td></tr><tr><td>Percentage</td></tr><tr><td></td></tr><tr><td>69.9%</td></tr><tr><td>30.1%</td></tr><tr><td></td></tr><tr><td>34.1%</td></tr><tr><td>23.8%</td></tr><tr><td></td></tr><tr><td>12.9%</td></tr><tr><td>8.1%</td></tr><tr><td>21.0%</td></tr><tr><td>17.7%</td></tr><tr><td>14.5%</td></tr... |
fe28d146b4b64255f7ab86669ac9e62224b1fe4825ef9d7cc498b28ae44a8d92.png | simple | <table><tr><td>Characteristic</td><td>Number</td><td>Percent</td></tr><tr><td>Age (in years)</td><td> </td><td> </td></tr><tr><td>15–24</td><td>5</td><td>33.3</td></tr><tr><td>25–34</td><td>6</td><td>40</td></tr><tr><td>35 or above</td><td>4</td><td>26.7</td></tr><tr><td>Education</td><td> </td><td> </td></... | <table><tr><td>Characteristic</td><td>Number</td><td>Percent</td></tr><tr><td>Age (in years)</td><td></td><td></td></tr><tr><td>15–24</td><td>5</td><td>33.3</td></tr><tr><td>25–34</td><td>6</td><td>40</td></tr><tr><td>35 or above</td><td>4</td><td>26.7</td></tr><tr><td>Education</td><td></td><td></td></tr><tr><td>Eleme... | <table><tr><td>Characteristic</td><td>Number</td><td>Percent</td></tr><tr><td>University</td><td>9</td><td>60</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td>Single</td><td>10</td><td>66.7</td></tr><tr><td>Married</td><td>5</td><td>33.3</td></tr><tr><td>Occupation</td><td></td><td></td></tr><tr><td>H... |
b028307bb619d65c2141e7dcdcacfde4dfdb4947ccbc8f409ac9883e98609386.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2" colspan="2">First yearTotalN = 298n (%)</td><td rowspan="2" colspan="2">Last yearTotalN = 209n (%)</td><td rowspan="2">P value</td><td colspan="4">Men</td><td rowspan="2">P value</td><td colspan="4">Women</td><td rowspan="2">P value</td></tr><tr><td colspan="2">First year... | <table><tr><td rowspan="2"></td><td rowspan="2" colspan="2">First yearTotalN = 298n (%)</td><td rowspan="2" colspan="2">Last yearTotalN = 209n (%)</td><td rowspan="2">P value</td><td colspan="4">Men</td></tr><tr><td colspan="2">First yearN = 125n (%)</td><td colspan="2">Last yearN = 77n (%)</td></tr><tr><td>Work</td><t... | <table><tr><td rowspan="2">P value</td><td colspan="4">Women</td><td rowspan="2">P value</td></tr><tr><td colspan="2">First yearN = 173n (%)</td><td colspan="2">Last yearN = 132n (%)</td></tr><tr><td>< .001</td><td>168</td><td>(97)</td><td>130</td><td>(98)</td><td>NS</td></tr><tr><td>NS</td><td>103</td><td>(60)</td><td... |
df79b14003e306d4278dd63c9f3ae5f352246f1f8ee9aaa2e4411513cee610d9.png | simple | <table><tr><td></td><td></td><td>VT IPD</td><td>NVT IPD</td><td>Total</td></tr><tr><td>Baseline</td><td></td><td>0</td><td>3765</td><td>3765</td></tr><tr><td>V, vaccine coverage</td><td>0.89</td><td></td><td></td><td></td></tr><tr><td></td><td>0.5</td><td>757</td><td>3594</td><td>4351</td></tr><tr><td></td><td>0.95</td... | <table><tr><td></td><td></td><td>VT IPD</td><td>NVT IPD</td><td>Total</td></tr><tr><td>Baseline</td><td></td><td>0</td><td>3765</td><td>3765</td></tr><tr><td>V, vaccine coverage</td><td>0.89</td><td></td><td></td><td></td></tr><tr><td></td><td>0.5</td><td>757</td><td>3594</td><td>4351</td></tr><tr><td></td><td>0.95</td... | <table><tr><td></td><td></td><td>VT IPD</td><td>NVT IPD</td><td>Total</td></tr><tr><td></td><td>0</td><td>0</td><td>3836</td><td>3836</td></tr><tr><td></td><td>1</td><td>2</td><td>3710</td><td>3712</td></tr><tr><td>cN</td><td>0.85</td><td></td><td></td><td></td></tr><tr><td></td><td>0</td><td>0</td><td>9533</td><td>953... |
00d5d2f9c4bbcd914bdf476737442fc3888d24c3371f7219620ae6f3a658e1e9.png | simple | <table><tr><td>Pathway</td><td>Number of Proteins in Pathway</td><td>Proteins from Gene List</td><td><i>P</i>-value</td><td>FDR</td><td>Genes</td></tr><tr><td>Pathways in cancer (K)</td><td>327</td><td>7</td><td>0.0004</td><td>1.40E-02</td><td>E2F1,PTEN,AKT2,MSH6,HSP90AA1,JUN,VEGFA</td></tr><tr><td>Direct p53 effectors... | <table><tr><td>Pathway</td><td>Number of Proteins in Pathway</td><td>Proteins from Gene List</td><td>P-value</td><td>FDR</td><td>Genes</td></tr><tr><td>Pathways in cancer (K)</td><td>327</td><td>7</td><td>0.0004</td><td>1.40E-02</td><td>E2F1,PTEN,AKT2,MSH6,HSP90AA1,JUN,VEGFA</td></tr><tr><td>Direct p53 effectors (N)</t... | <table><tr><td>Nonsense-mediated decay (R)</td><td>106</td><td>5</td><td>0.0001</td><td>1.55E-02</td><td>RPL30,UPF1,SMG7,RNPS1,RPL18A</td></tr><tr><td>RNA transport (K)</td><td>164</td><td>5</td><td>0.0006</td><td>1.50E-02</td><td>EEF1A1,UPF1,RNPS1,EIF4G2,NUP205</td></tr><tr><td>E2F transcription factor network (N)</td... |
9852f16d5b874bc348f22de7384a6e30f7dffb0e91a60b9d75930c2a7dd01f70.png | complex | <table><tr><td> </td><td> </td><td>Mean difference</td><td>SD (±)</td><td><i>P </i></td></tr><tr><td rowspan="3">Flat SimK (D)</td><td>IOL Master-Galilei</td><td>0.155</td><td>0.156</td><td><0.001</td></tr><tr><td>IOL Master-WAM 5500</td><td>0.007</td><td>0.187</td><td>0.302</td></tr><tr><td>Galilei-WAM 5500</t... | <table><tr><td></td><td></td><td>Mean difference</td><td>SD (±)</td><td>P</td></tr><tr><td>Flat SimK (D)</td><td>IOL Master-Galilei</td><td>0.155</td><td>0.156</td><td><0.001</td></tr></table> | <table><tr><td rowspan="2">Flat SimK (D)</td><td>IOL Master-WAM 5500</td><td>0.007</td><td>0.187</td><td>0.302</td></tr><tr><td>Galilei-WAM 5500</td><td>−0.148</td><td>0.195</td><td><0.001</td></tr><tr><td rowspan="3">Steep SimK (D)</td><td>IOL Master-Galilei</td><td>0.171</td><td>0.168</td><td><0.001</td></tr><tr><td>... |
11ae47b91f58df91963ee4627e0a721e7054ff4ece1438c1c543cbe79ff2f550.png | simple | <table><tr><td>Programs</td><td>Species</td><td>Algorithms</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Diana-microT</td><td>Human</td><td>Seed match, thermodynamics</td><td>Prefers target structure before seed pairing.</td><td>Absence of cooperativity and multiplicity of miRNAbinding sites.Conservation fi... | <table><tr><td>Programs</td><td>Species</td><td>Algorithms</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Diana-microT</td><td>Human</td><td>Seed match, thermodynamics</td><td>Prefers target structure before seed pairing.</td><td>Absence of cooperativity and multiplicity of miRNAbinding sites.Conservation fi... | <table><tr><td>Programs</td><td>Species</td><td>Algorithms</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>cTar</td><td>ies, worms</td><td> HMM</td><td>ders cross-species conservation to reduce falsepositives.</td><td>e sites prediction.</td></tr><tr><td>PITA</td><td>Human, mouse, fly, worm</td><td>Seed match... |
9927c9a53ce7a3bc12b4c750dd2015c0600743a5a8ccac0681233dfc2f611399.png | complex | <table><tr><td rowspan="2"></td><td></td><td></td><td>Non-surgical <i>n</i> = 261</td><td>Bariatric surgery <i>n</i> = 301</td><td>Adjusted for gender/ age/BMI</td><td></td><td></td></tr><tr><td>Range</td><td>α</td><td>Mean (SD)</td><td>Mean (SD)</td><td>F</td><td><i>p</i></td><td>ηp<sup>2</sup></td></tr><tr>... | <table><tr><td rowspan="2"></td></tr><tr></tr><tr><td>Self-esteem</td></tr><tr><td>Body satisfaction</td></tr><tr><td>Appearance importance</td></tr><tr><td>Mental health</td></tr><tr><td>- Anxiety</td></tr><tr><td>- Depression</td></tr><tr><td>Binge eating</td></tr><tr><td>Stressful life events</td></tr><tr><td>-frequ... | <table><tr><td></td><td></td><td>Non-surgical n = 261</td><td>Bariatric surgery n = 301</td><td>Adjusted for gender/ age/BMI</td><td></td><td></td></tr><tr><td>Range</td><td>α</td><td>Mean (SD)</td><td>Mean (SD)</td><td>F</td><td>p</td><td>ηp2</td></tr><tr><td>1–4</td><td>0.81</td><td>2.7 (0.7)</td><td>2.7 (0.7)</td><t... |
50fc028b71253a921de3957b0746bc6b25895b1f2cbf252812e8b79dfc9820aa.png | simple | <table><tr><td>Parameter</td><td>Description</td></tr><tr><td>L</td><td>ORF length in codons</td></tr><tr><td>x</td><td>average number of transcripts per cell</td></tr><tr><td>g</td><td>ribosome density in number of ribosomes per 100 codons</td></tr><tr><td>w</td><td>number of ribosomes attached to a single transcript<... | <table><tr><td>Parameter</td><td>Description</td></tr><tr><td>L</td><td>ORF length in codons</td></tr><tr><td>x</td><td>average number of transcripts per cell</td></tr><tr><td>g</td><td>ribosome density in number of ribosomes per 100 codons</td></tr><tr><td>w</td><td>number of ribosomes attached to a single transcript<... | <table><tr><td></td><td>slation elongation time</td></tr><tr><td>e</td><td>mean time required for elongation of one codon of a transcript</td></tr><tr><td>b</td><td>number of proteins produced from a single transcript during its lifespan</td></tr><tr><td>B</td><td>total number of protein molecules produced from all tra... |
d35b21c18664753a1482f56ab35220663f313a34ef5f5a258defe287e2bee279.png | simple | <table><tr><td>Tissue/Organ</td><td>Weighting factor</td></tr><tr><td>Breast, colon, lungs, red marrow, remainder, stomach</td><td>0.12</td></tr><tr><td>Gonads</td><td>0.08</td></tr><tr><td>Bladder, liver, esophagus, thyroid</td><td>0.04</td></tr><tr><td>Bone surfaces, brain, salivary glands, skin</td><td>0.01</td></tr... | <table><tr><td>Tissue/Organ</td></tr><tr><td>Breast, colon, lungs, red marrow, remainder, stomach</td></tr><tr><td>Gonads</td></tr><tr><td>Bladder, liver, esophagus, thyroid</td></tr><tr><td>Bone surfaces, brain, salivary glands, skin</td></tr></table> | <table><tr><td>Weighting factor</td></tr><tr><td>0.12</td></tr><tr><td>0.08</td></tr><tr><td>0.04</td></tr><tr><td>0.01</td></tr></table> |
e54c93be8956e702bf9860fa8e704d409d23324ed5cf3cd9af2e57b4aa00106a.png | complex | <table><tr><td rowspan="2">Criteria</td><td>O157</td><td>O26</td><td>O103</td><td>O111</td><td>O145</td><td>O45</td><td>O91</td><td>O113</td><td>O121</td><td>O128</td></tr><tr><td>(6)</td><td>(27)</td><td>(8)</td><td>(17)</td><td>(8)</td><td>(8)</td><td>(12)</td><td>(4)</td><td>(11)</td><td>(6)</td></tr><tr><td>Spring ... | <table><tr><td rowspan="2">Criteria</td><td>O157</td><td>O26</td><td>O103</td><td>O111</td><td>O145</td><td>O45</td><td>O91</td><td>O113</td><td>O121</td><td>O128</td></tr><tr><td>(6)</td><td>(27)</td><td>(8)</td><td>(17)</td><td>(8)</td><td>(8)</td><td>(12)</td><td>(4)</td><td>(11)</td><td>(6)</td></tr><tr><td>Spring ... | <table><tr><td rowspan="2">Criteria</td><td>O157</td><td>O26</td><td>O103</td><td>O111</td><td>O145</td><td>O45</td><td>O91</td><td>O113</td><td>O121</td><td>O128</td></tr><tr><td>(6)</td><td>(27)</td><td>(8)</td><td>(17)</td><td>(8)</td><td>(8)</td><td>(12)</td><td>(4)</td><td>(11)</td><td>(6)</td></tr><tr><td>Other c... |
acd630d07a72900833ee14629f2e33201406c522f2958394283524d464ca1a31.png | simple | <table><tr><td>Load Cases</td><td>No. of Locations</td><td>Load Cases</td><td>No. of Locations</td></tr><tr><td>Load Case 3-1</td><td>3</td><td>Load Case 3-7</td><td>4</td></tr><tr><td>Load Case 3-2</td><td>5</td><td>Load Case 3-8</td><td>6</td></tr><tr><td>Load Case 3-3</td><td>7</td><td>Load Case 3-9</td><td>8</td></... | <table><tr><td>Load Cases</td><td>No. of Locations</td><td>Load Cases</td><td>No. of Locations</td></tr></table> | <table><tr><td>Load Case 3-1</td><td>3</td><td>Load Case 3-7</td><td>4</td></tr><tr><td>Load Case 3-2</td><td>5</td><td>Load Case 3-8</td><td>6</td></tr><tr><td>Load Case 3-3</td><td>7</td><td>Load Case 3-9</td><td>8</td></tr><tr><td>Load Case 3-4</td><td>9</td><td>Load Case 3-10</td><td>10</td></tr><tr><td>Load Case 3... |
de86b55e585661f30c55804790f5f3b6ae6b287e32c710ad26b44d6be8d1f3fe.png | simple | <table><tr><td></td><td>Bipolar I disorder (<i>N</i> = 14) <i>N</i> (%)</td><td>Bipolar spectrum disorder (<i>N</i> = 26) <i>N</i> (%)</td><td>Bipolar disorder total (<i>N</i> = 40) <i>N</i> (%)</td><td>Significance Fisher exact test</td></tr><tr><td>Recognized past depressive episodes</td><td>11 (78.6)</td><td>22 (84.... | <table><tr><td></td></tr><tr><td>Recognized past depressive episodes</td></tr><tr><td>Recognized past (hypo)manic episodes</td></tr><tr><td>Consulted health professional for depressive episodes</td></tr><tr><td>Consulted health professional for (hypo)manic episodes</td></tr><tr><td>Hospitalization for a manic episode</... | <table><tr><td>Bipolar I disorder (N = 14) N (%)</td><td>Bipolar spectrum disorder (N = 26) N (%)</td><td>Bipolar disorder total (N = 40) N (%)</td><td>Significance Fisher exact test</td></tr><tr><td>11 (78.6)</td><td>22 (84.6)</td><td>33 (82.5)</td><td>ns</td></tr><tr><td>3 (21.4)</td><td>6 (23.1)</td><td>9 (22.5)</td... |
5410f12f03ab3ed6f28531e0f316aedf7688591fecd4782d64e31e7bf67a4020.png | complex | <table><tr><td>Ethnicity</td><td colspan="2">MKT</td><td colspan="2">WPA</td><td colspan="2">MLA</td><td colspan="2">Total</td></tr><tr><td>Sgaw Karen</td><td>1,081</td><td>26.3%</td><td>1,470</td><td>32.0%</td><td>3,443</td><td>71.3%</td><td>5,994</td><td>44.3%</td></tr><tr><td>Poe Karen</td><td>456</td><td>11.1%</td>... | <table><tr><td>Ethnicity</td><td colspan="2">MKT</td><td colspan="2">WPA</td><td colspan="2">MLA</td><td colspan="2">Total</td></tr><tr><td>Sgaw Karen</td><td>1,081</td><td>26.3%</td><td>1,470</td><td>32.0%</td><td>3,443</td><td>71.3%</td><td>5,994</td><td>44.3%</td></tr><tr><td>Poe Karen</td><td>456</td><td>11.1%</td>... | <table><tr><td>“Muslim”</td><td>15</td><td>0.4%</td><td>11</td><td>0.2%</td><td>573</td><td>11.9%</td><td>599</td><td>4.4%</td></tr><tr><td>Mon</td><td>72</td><td>1.8%</td><td>56</td><td>1.2%</td><td>14</td><td>0.3%</td><td>142</td><td>1.1%</td></tr><tr><td>Kachin</td><td>2</td><td>0.0%</td><td>0</td><td>0.0%</td><td>1... |
678786ad7157bc41300858b40a80fcf3483b290a4fe91bbbd38c00ff1478b6c7.png | simple | <table><tr><td></td><td>Y</td><td>J</td><td>P</td><td>I</td></tr><tr><td>ABNER(B)</td><td>54.2</td><td>60.8</td><td>62.0</td><td>54.0</td></tr><tr><td>BANNER</td><td>62.0</td><td>61.0</td><td>68.7</td><td>53.9</td></tr></table> | <table><tr><td></td><td>Y</td><td>J</td><td>P</td><td>I</td></tr><tr><td>ABNE</td><td></td><td>60</td><td></td><td>54.0</td></tr></table> | <table><tr><td>R(B)</td><td>54.2</td><td>.8</td><td>62.0</td><td></td></tr><tr><td>BANNER</td><td>62.0</td><td>61.0</td><td>68.7</td><td>53.9</td></tr></table> |
0a66e0ba80beb546c064673a3ead28af6f992e5e064c7cc71038278839ba27e7.png | simple | <table><tr><td><i>Extend_thres</i></td><td>P</td><td>R</td><td>F</td><td>Sn</td><td>PPV</td><td>Acc</td></tr><tr><td>0.05</td><td>0.506</td><td>0.314</td><td>0.387</td><td>0.569</td><td>0.389</td><td>0.471</td></tr><tr><td>0.1</td><td>0.589</td><td>0.36</td><td>0.447</td><td>0.521</td><td>0.541</td><td>0.531</td></tr><... | <table><tr><td>Extend_thres</td><td>P</td><td>R</td><td>F</td><td>Sn</td><td>PPV</td><td>Acc</td></tr><tr><td>0.05</td><td>0.506</td><td>0.314</td><td>0.387</td><td>0.569</td><td>0.389</td><td>0.471</td></tr><tr><td>0.1</td><td>0.589</td><td>0.36</td><td>0.447</td><td>0.521</td><td>0.541</td><td>0.531</td></tr><tr><td>... | <table><tr><td>0.3</td><td>24</td><td>.321</td><td>.398</td><td>39</td><td>.653</td><td>.505</td></tr><tr><td>0.4</td><td>0.515</td><td>0.311</td><td>0.388</td><td>0.349</td><td>0.677</td><td>0.486</td></tr><tr><td>0.5</td><td>0.506</td><td>0.314</td><td>0.387</td><td>0.332</td><td>0.699</td><td>0.482</td></tr><tr><td>... |
97320fa28c7889396ac5117d02a1889bc9ac98988099b87291d6933fd831e6bd.png | simple | <table><tr><td>Control</td><td>PaDRw-25 (t48)</td><td>PaDRw-25 (t72)</td></tr><tr><td>Peak (cm<sup>−1</sup>)</td><td>Peak (cm<sup>−1</sup>)</td><td>Peak (cm<sup>−1</sup>)</td></tr><tr><td>3306 (p, c)</td><td>3308 (+2)</td><td>3308 (+2)</td></tr><tr><td>2957 (p, l)</td><td>2958 (+1)</td><td>2958 (+1)</... | <table><tr><td>Control</td><td>PaDRw-25 (t48)</td><td>PaDRw-25 (t72)</td></tr></table> | <table><tr><td>Peak (cm−1)</td><td>Peak (cm−1)</td><td>Peak (cm−1)</td></tr><tr><td>3306 (p, c)</td><td>3308 (+2)</td><td>3308 (+2)</td></tr><tr><td>2957 (p, l)</td><td>2958 (+1)</td><td>2958 (+1)</td></tr><tr><td>2922 (l)</td><td>2921 (−1)</td><td>2922</td></tr><tr><td>2869 (p, l)</td><td>2874 (+5)</td><td>2875 (+6)</... |
b8ef6bf0b412f61b5d3530186468e521646c8f15e5b45a538e93b7a4b11c62e6.png | simple | <table><tr><td> </td><td>XX18</td><td>YY18</td><td>XY18</td><td>1818</td><td>Total Disomy</td></tr><tr><td>3PBA</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤LOD (n = 33)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td>>LOD (n = 42)</td><td>1.00 (0.90, 1.... | <table><tr><td></td><td>XX18</td><td>YY18</td><td>XY18</td><td>1818</td></tr><tr><td>3PBA</td><td></td><td></td><td></td><td></td></tr><tr><td>≤LOD (n = 33)</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td>>LOD (n = 42)</td><td>1.00 (0.90, 1.10)</td><td>1.28 (1.15, 1.42)</td><td>0.82 (0.77, 0.87)</t... | <table><tr><td>Total Disomy</td></tr><tr><td></td></tr><tr><td>1.00</td></tr><tr><td>0.93 (0.87, 0.97)</td></tr><tr><td></td></tr><tr><td>1.00</td></tr><tr><td>1.12 (1.06, 1.17)</td></tr><tr><td></td></tr><tr><td>1.00</td></tr><tr><td>1.09 (1.04, 1.15)</td></tr></table> |
c0ed39d03f0f1497682b7ae2b6b6d7c184b8c5a2c25b91746e227014fdd8e752.png | complex | <table><tr><td colspan="2">Genetic model</td><td>OR (95% CI)</td><td><i>P</i> heterogeneity</td></tr><tr><td>Co-dominant model</td><td>CC</td><td>1</td><td></td></tr><tr><td></td><td>CT</td><td>1.072 (0.843, 1.362)<sup>b</sup></td><td>0.025</td></tr><tr><td></td><td>TT</td><td>1.666 (1.127, 2.461)<sup>a</sup></td><td>0... | <table><tr><td colspan="2">Genetic model</td><td>OR (95% CI)</td><td>P heterogeneity</td></tr><tr><td>Co-dominant model</td><td>CC</td><td>1</td><td></td></tr><tr><td></td><td>CT</td><td>1.072 (0.843, 1.362)b</td><td>0.025</td></tr></table> | <table><tr><td colspan="2">Genetic model</td><td>OR (95% CI)</td><td>P heterogeneity</td></tr><tr><td></td><td>TT</td><td>1.666 (1.127, 2.461)a</td><td>0.991</td></tr><tr><td>Dominant model</td><td>CT+TT vs. CC</td><td>1.119 (0.899, 1.392)b</td><td>0.050</td></tr><tr><td>Recessive model</td><td>CC+CT vs. TT</td><td>1.6... |
65ebc13e1090e4a179651eb945134b576a72904cd4854a9db280858c0da1641f.png | simple | <table><tr><td>Chromosome</td><td>Start</td><td>End</td><td>Length</td><td>Score</td></tr><tr><td>1</td><td>82955709</td><td>82956371</td><td>663</td><td>306.0</td></tr><tr><td>7</td><td>1194442</td><td>1195252</td><td>811</td><td>286.97</td></tr><tr><td>1</td><td>76438827</td><td>76439515</td><td>689</td><td>251.83</t... | <table><tr><td>Chromosome</td><td>Start</td><td>End</td><td>Length</td><td>Score</td></tr></table> | <table><tr><td>1</td><td>82955709</td><td>82956371</td><td>663</td><td>306.0</td></tr><tr><td>7</td><td>1194442</td><td>1195252</td><td>811</td><td>286.97</td></tr><tr><td>1</td><td>76438827</td><td>76439515</td><td>689</td><td>251.83</td></tr><tr><td>5</td><td>4911834</td><td>4912728</td><td>895</td><td>236.06</td></t... |
9263c6d9e984570eb9cf0ec5816e8da3dbaf5abfce669b7216bbd8c28146b0f9.png | simple | <table><tr><td>Number of SNPs</td><td>Haplotype combination</td><td>Chromosomal position</td><td><i>P</i>value</td><td>FWER corrected <i>P</i>value</td></tr><tr><td>2</td><td>rs2268493-rs2254298</td><td>8800840-8802228</td><td>0.00086</td><td>0.00468</td></tr><tr><td>3</td><td>rs2268490-rs2268493-rs2254298</td><td>8797... | <table><tr><td>Number of SNPs</td><td>Haplotype combination</td><td>Chromosomal position</td><td>Pvalue</td><td>FWER corrected Pvalue</td></tr><tr><td>2</td><td>rs2268493-rs2254298</td><td>8800840-8802228</td><td>0.00086</td><td>0.00468</td></tr><tr><td>3</td><td>rs2268490-rs2268493-rs2254298</td><td>8797085-8802228</t... | <table><tr><td>4</td><td>rs237885-rs2268490-rs2268493-rs2254298</td><td>8795543-8802228</td><td>0.0012</td><td>0.00712</td></tr><tr><td>4</td><td>rs2268490- rs2268493-rs2254298-rs53576</td><td>8797085-8804371</td><td>0.00132</td><td>0.0079</td></tr></table> |
877a712b8732914055f462e97b781d2621435fbaaff5a176ecbbe7deb0a200e2.png | simple | <table><tr><td>Gene</td><td>Wt</td><td>Het</td><td>Null</td></tr><tr><td>IL-17A</td><td>7.62 ± 4.70∗</td><td>1.10 ± 0.32<sup>‡</sup></td><td>0.31 ± 0.01<sup>‡</sup></td></tr><tr><td>IL-17F</td><td>12.95 ± 3.71∗</td><td>5.46 ± 1.07<sup>‡</sup></td><td>4.19 ± 0.... | <table><tr><td>Gene</td><td>Wt</td><td>Het</td><td>Null</td></tr><tr><td>IL-17A</td><td>7.62 ± 4.70∗</td><td>1.10 ± 0.32‡</td><td>0.31 ± 0.01‡</td></tr><tr><td>IL-17F</td><td>12.95 ± 3.71∗</td><td>5.46 ± 1.07‡</td><td>4.19 ± 0.98‡</td></tr><tr><td>IL-21</td><td>1.53 ± 0.80</td><td>0.70 ± 0.18</td><td>0.47 ± 0.14</td></... | <table><tr><td>IL-27</td><td>2.75 ± 0.67</td><td>1.86 ± 0.42</td><td>1.80 ± 0.46</td></tr><tr><td>CCL20</td><td>1.42 ± 0.49</td><td>1.36 ± 0.57</td><td>1.13 ± 0.30</td></tr><tr><td>CCR6</td><td>1.22 ± 0.38</td><td>0.82 ± 0.24</td><td>0.91 ± 0.44</td></tr><tr><td>RORγτ</td><td>11.07 ± 2.04∗</td><td>8.75 ± 1.34∗</td><td>... |
1e07957cf6fbf868f1457956cd1423878d1612eae03ce64bd1eea6a6b4ead10b.png | complex | <table><tr><td>Efficacy measures</td><td>Baseline</td><td>Week 12</td><td>Week 24</td></tr><tr><td colspan="4">6MWD, meters (LOCF)</td></tr><tr><td> <i>N</i></td><td>133</td><td>133</td><td>133</td></tr><tr><td> Mean (SD)</td><td>377.1 (61.30)</td><td>+53.6 (64.50)</td><td>+64.4 (91.17)</td></tr><tr><td> *<i>P</i> valu... | <table><tr><td>Efficacy measures</td><td>Baseline</td><td>Week 12</td><td>Week 24</td></tr><tr><td colspan="4">6MWD, meters (LOCF)</td></tr><tr><td>N</td><td>133</td><td>133</td><td>133</td></tr><tr><td>Mean (SD)</td><td>377.1 (61.30)</td><td>+53.6 (64.50)</td><td>+64.4 (91.17)</td></tr><tr><td>*P value (95 % CI)</td><... | <table><tr><td>Efficacy measures</td><td>Baseline</td><td>Week 12</td><td>Week 24</td></tr><tr><td>Improved by class 1/2</td><td></td><td>44 (33.1)/0</td><td>51 (38.3)/0</td></tr><tr><td>No change</td><td></td><td>84 (63.2)</td><td>77 (57.9)</td></tr><tr><td>Worsened by class 1/2</td><td></td><td>4 (3.0)/1 (0.8)</td><t... |
3ae7d8e0c931c0f8ec5d0eaa14b9c3707f7e7f16a3c82817b31df6d3bcddf6a2.png | simple | <table><tr><td>Direction of the Acceleration Loaded</td><td>Maximum Differential Stress of <i>x</i>-Component (MPa)</td><td>Maximum Differential Stress of <i>y</i>-Component (MPa)</td><td>Maximum Differential Stress of <i>z</i>-Component (MPa)</td></tr><tr><td><i>x</i>-axis</td><td>0.00048</td><td>14.7</td><td>0.00036<... | <table><tr><td>Direction of the Acceleration Loaded</td><td>Maximum Differential Stress of x-Component (MPa)</td><td>Maximum Differential Stress of y-Component (MPa)</td><td>Maximum Differential Stress of z-Component (MPa)</td></tr></table> | <table><tr><td>x-axis</td><td>0.00048</td><td>14.7</td><td>0.00036</td></tr><tr><td>y-axis</td><td>0.0009</td><td>0.00025</td><td>0.00065</td></tr><tr><td>z-axis</td><td>0.00014</td><td>0.000172</td><td>0.000354</td></tr></table> |
b5c79dd08ed3d40f25a992ae35aee616465a9bbf26028de06ccfa6c721f2880c.png | simple | <table><tr><td>Participant</td><td>No motor constant load VOL</td><td>No motor constant load FES</td><td>No motor incremental load VOL</td><td>No motor incremental load FES</td><td>Motor constant load VOL</td><td>Motor constant load FES</td><td>Motor incremental load VOL</td><td>Other cycling trials completed</td></tr>... | <table><tr><td>Participant</td><td>No motor constant load VOL</td><td>No motor constant load FES</td><td>No motor incremental load VOL</td><td>No motor incremental load FES</td><td>Motor constant load VOL</td><td>Motor constant load FES</td><td>Motor incremental load VOL</td><td>Other cycling trials completed</td></tr>... | <table><tr><td>3</td><td>×</td><td></td><td></td><td></td><td>×</td><td>×</td><td></td><td></td></tr><tr><td>4</td><td></td><td></td><td></td><td></td><td>×</td><td>×</td><td>×</td><td>No motor-Brief trial without FES assistance</td></tr></table> |
ecd2225376c392442d19b3e8e239d9f0faec2fd1bd20ee70f40ea3c1d9773561.png | simple | <table><tr><td>Event sequence</td><td>WBC (×10<sup>9</sup>)</td><td>Eosinophils in PB (%, AEC)</td><td>Eosinophils in BM (%)</td><td>Blasts in BM (%)</td><td>Diagnosis</td><td>Intervention</td><td>Disease status</td></tr><tr><td>Initial presentation</td><td>44.6</td><td>1, 0.45</td><td>1</td><td>7</td><td>CMML-1</... | <table><tr><td>Event sequence</td><td>WBC (×109)</td><td>Eosinophils in PB (%, AEC)</td><td>Eosinophils in BM (%)</td><td>Blasts in BM (%)</td><td>Diagnosis</td><td>Intervention</td><td>Disease status</td></tr></table> | <table><tr><td>Initial presentation</td><td>44.6</td><td>1, 0.45</td><td>1</td><td>7</td><td>CMML-1</td><td>SGI-110</td><td>Refractory</td></tr><tr><td>After 2 months</td><td>65.1</td><td>9, 5.8</td><td>5</td><td>4</td><td>CMML-1</td><td>SGI-110</td><td>Progression</td></tr><tr><td>After 1 month</td><td>126</td><td>11,... |
e2f0cdac9fb321da2ba3e0d757588c8fe0641eb3a7e535859b2615a87a1a4454.png | simple | <table><tr><td>Gene name</td><td>Forward primer</td><td>Reverse primer</td></tr><tr><td><i>IL-6</i></td><td>5′-ATCTGCCCTTCAGGAACAGC-3′</td><td>5′-AGCCTCCGACTTGTGAAGTG-3′</td></tr><tr><td><i>STAT3</i></td><td>5′-CAAAGAAAACATGGCCGGCA-3′</td><td>5′-GGGGGCTTTGTGCTTAGGAT-3′</t... | <table><tr><td></td><td>Forward pr</td><td>Re</td></tr></table> | <table><tr><td>Gene name</td><td>imer</td><td>verse primer</td></tr><tr><td>IL-6</td><td>5′-ATCTGCCCTTCAGGAACAGC-3′</td><td>5′-AGCCTCCGACTTGTGAAGTG-3′</td></tr><tr><td>STAT3</td><td>5′-CAAAGAAAACATGGCCGGCA-3′</td><td>5′-GGGGGCTTTGTGCTTAGGAT-3′</td></tr><tr><td>JAK-1</td><td>5′-ATGGAGTTTCTGCCTTCGGG-3′</td><td>5′-TTCTTGC... |
23feeb58bab99f0ffc74c36e5ca427842a29d1da364adabfe5147e43a21a9d83.png | simple | <table><tr><td></td><td>Total</td><td>FOBT</td><td>Colonoscopy/sigmoidoscopy</td></tr><tr><td>% Ordered</td><td>48</td><td>33</td><td>26</td></tr><tr><td>% Completed</td><td>43</td><td>23</td><td>26</td></tr></table> | <table><tr><td></td><td>Total</td><td>FOBT</td><td>Colonoscopy/sigmoidoscopy</td></tr><tr><td>% Ordered</td><td>48</td><td>33</td><td>26</td></tr></table> | <table><tr><td>% Completed</td><td>43</td><td>23</td><td>26</td></tr></table> |
37881e4d40b3ac0884ef98947d86bb9b6981e9fd13b34e45f3d1ad39f6c2a55f.png | complex | <table><tr><td colspan="2">Method</td><td>FPS</td></tr><tr><td rowspan="7">Ours</td><td>K-SVD & Lasso</td><td>482</td></tr><tr><td>K-SVD & Ridge</td><td>34</td></tr><tr><td>K-SVD & Elastic Net</td><td>27</td></tr><tr><td>DMM & SVM</td><td>87</td></tr><tr><td>DMM & RF</td><td>215</td></tr><tr><td>LBP... | <table><tr><td colspan="2">Method</td><td>FPS</td></tr><tr><td rowspan="4">Ours</td><td>K-SVD & Lasso</td><td>482</td></tr><tr><td>K-SVD & Ridge</td><td>34</td></tr><tr><td>K-SVD & Elastic Net</td><td>27</td></tr><tr><td>DMM & SVM</td><td>87</td></tr></table> | <table><tr><td rowspan="3">Ours</td><td>DMM & RF</td><td>215</td></tr><tr><td>LBP & SVM</td><td>62</td></tr><tr><td>LBP & RF</td><td>159</td></tr><tr><td rowspan="3"></td><td>MEMM [12]</td><td>10</td></tr><tr><td>Orderlet [24]</td><td>25</td></tr><tr><td>DNBC [36]</td><td>7</td></tr></table> |
94b3af86795610f5df9afd444cacc5c0886962e080427dc2f485ef56a832a2cb.png | complex | <table><tr><td>Lymphoma type</td><td colspan="4">Mean MFI relative to normal B cells (SEM)</td></tr><tr><td> </td><td>IgM</td><td>IgG</td><td>CD79a</td><td>CD79b</td></tr><tr><td>MZL</td><td>0.23 (0.62)</td><td>−0.21 (0.28)</td><td>0.19 (0.33)</td><td>−1.29 (0.43)</td></tr><tr><td>SLL/CLL</td><td>−1.3... | <table><tr><td>Lymphoma type</td><td colspan="4">Mean MFI relative to normal B cells (SEM)</td></tr><tr><td></td><td>I</td><td>IgG</td><td></td><td>C</td></tr></table> | <table><tr><td></td><td>gM</td><td></td><td>CD79a</td><td>D79b</td></tr><tr><td>MZL</td><td>0.23 (0.62)</td><td>−0.21 (0.28)</td><td>0.19 (0.33)</td><td>−1.29 (0.43)</td></tr><tr><td>SLL/CLL</td><td>−1.38 (0.38)</td><td>−0.38 (0.24)</td><td>−0.15 (0.18)</td><td>−2.04 (0.32)</td></tr></table> |
421f95b2b1f1deb96638770cab12c283fde49944f956b6b09948829b2607ab38.png | simple | <table><tr><td>GOJ subtypes</td><td>Type I (Adenocarcinoma of distal oesophagus)</td><td>Type II (True cardia carcinoma)</td><td>Type III (Sub-cardial carcinoma)</td></tr><tr><td>Endoscopic criteria</td><td>Tumour mass arises 1 to 5 cm above the endoscopic cardia</td><td>Tumour mass arises 1 cm above to 2 cm below the ... | <table><tr><td>GOJ subtypes</td><td>Type I (Adenocarcinoma of distal oesophagus)</td><td>Type II (True cardia carcinoma)</td><td>Type III (Sub-cardial carcinoma)</td></tr><tr><td>Endoscopic criteria</td><td>Tumour mass arises 1 to 5 cm above the endoscopic cardia</td><td>Tumour mass arises 1 cm above to 2 cm below the ... | <table><tr><td>GOJ subtypes</td><td>Type I (Adenocarcinoma of distal oesophagus)</td><td>Type II (True cardia carcinoma)</td><td>Type III (Sub-cardial carcinoma)</td></tr><tr><td>Lymph node metastases</td><td>To mediastinal and abdominal lymph node stations</td><td>Mainly to abdominal lymph node stations</td><td>Mainly... |
e28ccab4b8c2e7541651bb550e3a0795b718554501601858985c49d2904946de.png | simple | <table><tr><td></td><td>Adherence to ≥ 4 recommendation items(<i>n</i> = 385)</td><td>Adherence to < 4 recommendation items(<i>n</i> = 325)</td><td><i>p value</i></td><td>Overall cohort (<i>n</i> = 710)</td></tr><tr><td>Age, years, mean, (SD)</td><td>57.9 (8.77)</td><td>57.2 (9.64)</td><td><i>0.268</i></td><td... | <table><tr><td></td><td>Adherence to ≥ 4 recommendation items(n = 385)</td><td>Adherence to < 4 recommendation items(n = 325)</td></tr><tr><td>Age, years, mean, (SD)</td><td>57.9 (8.77)</td><td>57.2 (9.64)</td></tr><tr><td>Males, n (%)</td><td>306 (79)</td><td>276 (85)</td></tr><tr><td>Education, years, mean (SD)</td><... | <table><tr><td>p value</td><td>Overall cohort (n = 710)</td></tr><tr><td>0.268</td><td>57.6 (9.18)</td></tr><tr><td>0.060</td><td>582 (82)</td></tr><tr><td>< 0.001</td><td>11.4 (3.48)</td></tr><tr><td>0.100</td><td></td></tr><tr><td></td><td>473 (67)</td></tr><tr><td></td><td>76 (11)</td></tr><tr><td></td><td>72 (10)</... |
900d9a858d3c3bd101041e0bb14c78bedaaac5b2b7afdacfb99fe8e14c1f5e5e.png | complex | <table><tr><td>CAM preparation</td><td>% (n)</td></tr><tr><td colspan="2">Homeopathy</td></tr><tr><td> Schuessler Salts</td><td>3.1 (11)</td></tr><tr><td colspan="2">Dietary supplements</td></tr><tr><td> Minerals</td><td> </td></tr><tr><td>Magnesium</td><td>13.5 (48)</td></tr><tr><td>Calcium</td><td>9.0 (32)</td></tr><... | <table><tr><td>CAM preparation</td><td>% (n)</td></tr><tr><td colspan="2">Homeopathy</td></tr><tr><td>Schuessler Salts</td><td>3.1 (11)</td></tr><tr><td colspan="2">Dietary supplements</td></tr></table> | <table><tr><td>CAM preparation</td><td>% (n)</td></tr><tr><td>Minerals</td><td></td></tr><tr><td>Magnesium</td><td>13.5 (48)</td></tr><tr><td>Calcium</td><td>9.0 (32)</td></tr><tr><td>Zinc</td><td>2.5 (9)</td></tr><tr><td>Iron</td><td>2.0 (7)</td></tr><tr><td>Single vitamins</td><td></td></tr><tr><td>Vitamin C</td><td>... |
fcf61df9c2e19ce2a0a971ca95848cbb69c25060faadd1124ca4709ec9173acd.png | simple | <table><tr><td>Target gene<sup>a</sup></td><td>Forward primer, reverse primer and probe sequences (5'-3')</td><td>Location within sequences</td><td>Gene Bank accession no.</td></tr><tr><td><i>nleG6-2 </i>(Z2150)</td><td>ATATGCTCTCTATATGATAAGGATG</td><td>1928877-1928901</td><td>AE005174</td></tr><tr><td></td><td>AAAGTGA... | <table><tr><td>Target genea</td><td>Forward primer, reverse primer and probe sequences (5'-3')</td><td>Location within sequences</td><td>Gene Bank accession no.</td></tr></table> | <table><tr><td>nleG6-2 (Z2150)</td><td>ATATGCTCTCTATATGATAAGGATG</td><td>1928877-1928901</td><td>AE005174</td></tr><tr><td></td><td>AAAGTGACATTCGTCTTTTCTCATA</td><td>1928996-1928872</td><td></td></tr><tr><td></td><td>[6FAM]CGTTAGTGCAACTTGTTGAAACTGGTGGAA[BHQ1]</td><td>1928902-1928931</td><td></td></tr><tr><td>nleG5-2 (Z... |
bafce8a9db7386c7bf4915d24b08ead18bf8f7491b5284ca7a6bb4c231691494.png | simple | <table><tr><td></td><td>Capital cost ($MM)</td><td>Additional chemical cost ($MM/year)</td><td>Description</td></tr><tr><td>Preprocessing unit</td><td>$10.17</td><td>$1.90</td><td>Preprocessing unit includes tanks for preprocessing and belt transfer conveyors, where the preprocessed biomass may be additionally washed</... | <table><tr><td></td><td>Capital cost ($MM)</td><td>Additional chemical cost ($MM/year)</td></tr><tr><td>Preprocessing unit</td><td>$10.17</td><td>$1.90</td></tr><tr><td>Wastewater treatment unita</td><td>$21.70</td><td>$3.00</td></tr></table> | <table><tr><td>Description</td></tr><tr><td>Preprocessing unit includes tanks for preprocessing and belt transfer conveyors, where the preprocessed biomass may be additionally washed</td></tr><tr><td>Additional cost account for the increase of the wastewater treatment capacity and treatment chemicals</td></tr></table> |
6370ab9cb05a7b6c57b5eb543fb601c4d3f69ae70d7fbedfdad4c4709d505fc7.png | simple | <table><tr><td>Parameters</td><td>B</td><td>Wald</td><td>Sig.</td><td>Exp (B)</td><td>95% CI</td></tr><tr><td>Age (≥60y)</td><td>0.913</td><td>0.996</td><td>0.318</td><td>2.491</td><td>0.415-14.957</td></tr><tr><td>Histological type</td><td>0.457</td><td>0.110</td><td>0.740</td><td>1.579</td><td>0.107-23.390</td>... | <table><tr><td>Parameters</td><td>B</td><td>Wald</td><td>Sig.</td><td>Exp (B)</td><td>95% CI</td></tr><tr><td>Age (≥60y)</td><td>0.913</td><td>0.996</td><td>0.318</td><td>2.491</td><td>0.415-14.957</td></tr></table> | <table><tr><td>Parameters</td><td>B</td><td>Wald</td><td>Sig.</td><td>Exp (B)</td><td>95% CI</td></tr><tr><td>Histological type</td><td>0.457</td><td>0.110</td><td>0.740</td><td>1.579</td><td>0.107-23.390</td></tr><tr><td>Grade</td><td>-1.369</td><td>3.599</td><td>0.058</td><td>0.254</td><td>0.062-1.046</td></tr><tr><t... |
e79ba17f769878ac9ad1559198833d9f84b8093f89a04c7538ea7cea5ea81542.png | simple | <table><tr><td>Antibiotics</td><td><i>S. aureus</i> (n = 30)Resistant frequency (%)</td><td>MRSA (n = 8)Resistant frequency (%)</td></tr><tr><td>Penicillin G</td><td>22 (73)</td><td>8 (100)</td></tr><tr><td>Ciprofloxacin</td><td>11 (36.7)</td><td>6 (75.0)</td></tr><tr><td>Gentamicin</td><td>10 (33.3)</td><td>5 (62.5)</... | <table><tr><td>Antibiotics</td><td>S. aureus (n = 30)Resistant frequency (%)</td><td>MRSA (n = 8)Resistant frequency (%)</td></tr><tr><td>Penicillin G</td><td>22 (73)</td><td>8 (100)</td></tr><tr><td>Ciprofloxacin</td><td>11 (36.7)</td><td>6 (75.0)</td></tr><tr><td>Gentamicin</td><td>10 (33.3)</td><td>5 (62.5)</td></tr... | <table><tr><td>Antibiotics</td><td>S. aureus (n = 30)Resistant frequency (%)</td><td>MRSA (n = 8)Resistant frequency (%)</td></tr><tr><td>Teicoplanin</td><td>0</td><td>0</td></tr><tr><td>Cefoxitin</td><td>8 (26.7)</td><td>8 (100)</td></tr><tr><td>Oxacillin</td><td>8 (26.7)</td><td>8 (100)</td></tr><tr><td>Clindamycin</... |
f7a84a20b3d0184b59fc7900f96d4275110f9361199a482ece6f18921708d305.png | complex | <table><tr><td rowspan="2">Index</td><td rowspan="2">Target group</td><td colspan="3">Number of drugs</td></tr><tr><td>Training dataset</td><td>Test dataset</td><td>Total</td></tr><tr><td>1</td><td>G Protein-coupled Receptors</td><td>272</td><td>35</td><td>307</td></tr><tr><td>2</td><td>Nuclear Receptors</td><td>82</td... | <table><tr><td>Index</td><td>Target group</td><td colspan="3">Number of drugs</td></tr></table> | <table><tr><td>Index</td><td>Target group</td><td>Training dataset</td><td>Test dataset</td><td>Total</td></tr><tr><td>1</td><td>G Protein-coupled Receptors</td><td>272</td><td>35</td><td>307</td></tr><tr><td>2</td><td>Nuclear Receptors</td><td>82</td><td>13</td><td>95</td></tr><tr><td>3</td><td>Ion Channels</td><td>10... |
8f0c5d6b98f040a02ac7e1b66378809fcafbb8ebcca29cc13e7a9a9c02b2a12a.png | simple | <table><tr><td>Variable</td><td>CAP due to other definite bacterial pathogensn = 621</td><td>p<sup>1</sup></td><td>MPP n = 307</td><td>p<sup>2</sup></td><td>CAP with no known bacterial etiology n = 3604</td></tr><tr><td>Age (∅ ± SD)</td><td>61 ± 17 years</td><td>.000</td><td>41 ± 16 years</td><td>.... | <table><tr><td>Variable</td><td>CAP due to other definite bacterial pathogensn = 621</td><td>p1</td><td>MPP n = 307</td><td>p2</td><td>CAP with no known bacterial etiology n = 3604</td></tr><tr><td>Age (∅ ± SD)</td><td>61 ± 17 years</td><td>.000</td><td>41 ± 16 years</td><td>.000</td><td>61 ± 18 years</td></tr><tr><td>... | <table><tr><td>Variable</td><td>CAP due to other definite bacterial pathogensn = 621</td><td>p1</td><td>MPP n = 307</td><td>p2</td><td>CAP with no known bacterial etiology n = 3604</td></tr><tr><td>Renal insufficiency</td><td>8%</td><td>.001</td><td>2%</td><td>.000</td><td>8%</td></tr><tr><td>Congestive heart failure</... |
6d72ef0e953c2f5b069487b08cef549e3a5ab614fd1e429a9652aba82c2d873a.png | simple | <table><tr><td>Gene name</td><td>Control Fold change Peak to Trough</td><td>Alcohol Fold change Peak to Trough</td><td>Ratio (Alcohol fed/control)</td></tr><tr><td><i>clock</i></td><td>3.1</td><td>3.5</td><td>1.1</td></tr><tr><td><i>Bmal1</i></td><td>14.9</td><td>10.7</td><td>0.7</td></tr><tr><td><i>Npas2</i></td><td>3... | <table><tr><td>Gene name</td></tr><tr><td>clock</td></tr><tr><td>Bmal1</td></tr><tr><td>Npas2</td></tr><tr><td>per1</td></tr><tr><td>per2</td></tr><tr><td>per3</td></tr><tr><td>cry1</td></tr><tr><td>cry2</td></tr><tr><td>Rev-erbα</td></tr><tr><td>Rev-erbβ</td></tr></table> | <table><tr><td>Control Fold change Peak to Trough</td><td>Alcohol Fold change Peak to Trough</td><td>Ratio (Alcohol fed/control)</td></tr><tr><td>3.1</td><td>3.5</td><td>1.1</td></tr><tr><td>14.9</td><td>10.7</td><td>0.7</td></tr><tr><td>38.5</td><td>8.0</td><td>0.2</td></tr><tr><td>5.9</td><td>6.2</td><td>1.1</td></tr... |
60559c87ac709ed3812c88cd82505594434dd8e5fab5f6455127de32127739dc.png | simple | <table><tr><td></td><td>AUC</td><td>Cut-off value</td><td>Sensitivity, % (95 % CI)</td><td>Specificity, % (95 % CI)</td><td>Likelihood ratio</td></tr><tr><td>BAFF</td><td>0.823</td><td>1.7 ng · mL<sup>−1</sup></td><td>67.6 (49.4 to 82.6)</td><td>94.7 (73.9 to 99.8)</td><td>12.85</td></tr><tr><td>KL-6</td><td... | <table><tr><td></td><td>AUC</td><td>Cut-off value</td><td>Sensitivity, % (95 % CI)</td><td>Specificity, % (95 % CI)</td><td>Likelihood ratio</td></tr><tr><td>BAFF</td><td>0.823</td><td>1.7 ng · mL−1</td><td>67.6 (49.4 to 82.6)</td><td>94.7 (73.9 to 99.8)</td><td>12.85</td></tr></table> | <table><tr><td></td><td>AUC</td><td>Cut-off value</td><td>Sensitivity, % (95 % CI)</td><td>Specificity, % (95 % CI)</td><td>Likelihood ratio</td></tr><tr><td>KL-6</td><td>0.566</td><td>1562 U · mL−1</td><td>79.4 (62.1 to 91.3)</td><td>52.6 (28.8 to 75.5)</td><td>1.67</td></tr><tr><td>SP-D</td><td>0.643</td><td>158 ng ·... |
5402eef10c956c426a8b461dc39d2de3259a7117b8c79f03550cb59bc7946d38.png | simple | <table><tr><td>Parameters</td><td><i>df</i></td><td><i>F</i>-Value</td><td><i>p</i>-value</td></tr><tr><td>Drug</td><td>1</td><td>2.288</td><td>0.138</td></tr><tr><td>Timepoint</td><td>6.932</td><td>2.163</td><td>0.038*</td></tr><tr><td>Stimulation</td><td>3</td><td>11.423</td><td>0.001*</td></tr><tr><td>Drug × st... | <table><tr><td>Parameters</td><td>df</td><td>F-Value</td><td>p-value</td></tr><tr><td>Drug</td><td>1</td><td>2.288</td><td>0.138</td></tr><tr><td>Timepoint</td><td>6.932</td><td>2.163</td><td>0.038*</td></tr><tr><td>Stimulation</td><td>3</td><td>11.423</td><td>0.001*</td></tr><tr><td>Drug × stimulation</td><td>3</td><t... | <table><tr><td>Parameters</td><td>df</td><td>F-Value</td><td>p-value</td></tr><tr><td>Drug × timepoint</td><td>5.446</td><td>1.478</td><td>0.192</td></tr><tr><td>Drug × timepoint × stimulation</td><td>30</td><td>1.831</td><td>0.027*</td></tr></table> |
c1247312317683ef466faf59819d70b05f5436823437960516f261d16ac8f71e.png | simple | <table><tr><td>Pathway<i><sup>2</sup></i></td><td>Sex</td><td>Diet</td><td><i>PAPOLG</i> genotype</td><td>Sex × diet</td><td>Sex × gene</td><td>Diet × gene</td></tr><tr><td>Amino acids (85)</td><td>11<i><sup>2</sup></i><i><sup>3</sup></i></td><td>3</td><td>8</td><td>1</td><td>2</td><td>4</td></tr><tr><td... | <table><tr><td>Pathway2</td><td>Sex</td><td>Diet</td><td>PAPOLG genotype</td><td>Sex × diet</td><td>Sex × gene</td><td>Diet × gene</td></tr><tr><td>Amino acids (85)</td><td>1123</td><td>3</td><td>8</td><td>1</td><td>2</td><td>4</td></tr><tr><td>Carbohydrates (23)</td><td>9</td><td>0</td><td>3</td><td>2</td><td>1</td><t... | <table><tr><td>Median number after Y scrambling3</td><td>20</td><td>17</td><td>20</td><td>20</td><td>20</td><td>20</td></tr><tr><td>4</td><td><0.001</td><td>NS</td><td><0.001</td><td>NS</td><td><0.001</td><td><0.001</td></tr></table> |
d8471c02c6f586fd7f1b427a9ade1984991b83943779a9ca4a31db1b42277e43.png | simple | <table><tr><td> </td><td>Hexanoyl-carnitine</td><td>Octenoyl-carnitine</td><td>Octanoyl-carnitine</td><td>Decenoyl-carnitine</td><td>Decanoyl-carnitine</td><td>Dodecenoyl-carnitine</td><td>Tetradecenoyl-carnitine</td><td>Linoleyl-carnitine</td><td>Stearoyl-carnitine</td></tr><tr><td>Hexanoylcarnitine</td><td>1</td><td>... | <table><tr><td></td><td>Hexanoyl-carnitine</td><td>Octenoyl-carnitine</td><td>Octanoyl-carnitine</td><td>Decenoyl-carnitine</td><td>Decanoyl-carnitine</td><td>Dodecenoyl-carnitine</td><td>Tetradecenoyl-carnitine</td><td>Linoleyl-carnitine</td><td>Stearoyl-carnitine</td></tr><tr><td>Hexanoylcarnitine</td><td>1</td><td>0... | <table><tr><td></td><td>Hexanoyl-carnitine</td><td>Octenoyl-carnitine</td><td>Octanoyl-carnitine</td><td>Decenoyl-carnitine</td><td>Decanoyl-carnitine</td><td>Dodecenoyl-carnitine</td><td>Tetradecenoyl-carnitine</td><td>Linoleyl-carnitine</td><td>Stearoyl-carnitine</td></tr><tr><td>Octenoylcarnitine</td><td>0.26</td><t... |
29ad2d97733be0d815a42e2f173cf4d60492e50868f3bafcb3caa50c06f40473.png | complex | <table><tr><td></td><td colspan="4">Coefficient (Standard Error)</td></tr><tr><td>Independent Variable</td><td>Initial Family Lifestyle</td><td>Family LifestyleAge 3</td><td>Family LifestyleAge 5</td><td>Family LifestyleAge 7</td></tr><tr><td></td><td colspan="4">α (Eq. 4)</td></tr><tr><td>Previous Latent Family L... | <table><tr><td></td><td colspan="2">Coefficient (Standard Error)</td></tr><tr><td>Independent Variable</td><td>Initial Family Lifestyle</td><td>Family LifestyleAge 3</td></tr><tr><td></td><td colspan="2">α (Eq. 4)</td></tr><tr><td>Previous Latent Family Lifestyle, α</td><td>–</td><td>1.094*** (0.007)</td></tr><tr><td><... | <table><tr><td colspan="2">Coefficient (Standard Error)</td></tr><tr><td>Family LifestyleAge 5</td><td>Family LifestyleAge 7</td></tr><tr><td colspan="2">α (Eq. 4)</td></tr><tr><td>1.094*** (0.007)</td><td>1.094*** (0.007)</td></tr><tr><td colspan="2">β(Eqs. 3 and 4)</td></tr><tr><td>–</td><td>–</td></tr><tr><td>–</td>... |
e61dfbbf214190fa409d553222ee2829057c50bd7c6e66c66f8c22404e5a2ad2.png | simple | <table><tr><td>Patient</td><td>Age (years)</td><td>Gender</td><td>Location</td><td>Primary malignancy</td><td>Metastases type</td><td>Treatment for primary malignancy</td></tr><tr><td>1</td><td>69</td><td>M</td><td>Right</td><td>Kidney cancer</td><td>S</td><td>Surgery, chemotherapy</td></tr><tr><td>2</td><td>65</td><td... | <table><tr><td>Patient</td><td>Age (years)</td><td>Gender</td><td>Location</td><td>Primary malignancy</td><td>Metastases type</td><td>Treatment for primary malignancy</td></tr><tr><td>1</td><td>69</td><td>M</td><td>Right</td><td>Kidney cancer</td><td>S</td><td>Surgery, chemotherapy</td></tr><tr><td>2</td><td>65</td><td... | <table><tr><td>Patient</td><td>Age (years)</td><td>Gender</td><td>Location</td><td>Primary malignancy</td><td>Metastases type</td><td>Treatment for primary malignancy</td></tr><tr><td>5</td><td>80</td><td>M</td><td>Right</td><td>Colon cancer</td><td>S</td><td>Surgery, chemotherapy</td></tr><tr><td>6</td><td>81</td><td>... |
f2f6311a8f810716f9fc62cf214cd8c8ceceb130e4bccca8147f1ffba451cc76.png | complex | <table><tr><td>Hip bearing surface</td><td>Femoral head size (mm)</td><td>Number of hips implanted</td><td>Number of hips revised for ARMD</td><td>Risk of ARMD revision surgery (%) (95% CI)</td><td>Relative risk (95% CI) of ARMD revision with 36 mm head size (vs. 28/32 mm)</td><td><i>p</i>-value (36 mm vs. 28/32 mm for... | <table><tr><td>Hip bearing surface</td><td>Femoral head size (mm)</td><td>Number of hips implanted</td><td>Number of hips revised for ARMD</td><td>Risk of ARMD revision surgery (%) (95% CI)</td><td>Relative risk (95% CI) of ARMD revision with 36 mm head size (vs. 28/32 mm)</td><td>p-value (36 mm vs. 28/32 mm for same b... | <table><tr><td>CoP</td><td>36</td><td>24,513</td><td>5</td><td>0.020 (0.007–0.048)</td><td>0.82 (0.24–2.19)</td><td>0.683</td></tr></table> |
af399431d8cec80dc4055c8b430c3d9270cdd2c49a03700d74aae8ff487d6af7.png | complex | <table><tr><td></td><td colspan="2">Model I*</td><td colspan="2">Model II**</td></tr><tr><td>Variable names</td><td>HR (95% CI)</td><td>P</td><td>HR (95% CI)</td><td>P</td></tr><tr><td>Care recipient's gender</td><td></td><td></td><td></td><td></td></tr><tr><td> Female</td><td>1.00</td><td></td><td>1.00</td><td></td></... | <table><tr><td></td><td>Model I*</td></tr><tr><td>Variable names</td><td>HR (95% CI)</td></tr><tr><td>Care recipient's gender</td><td></td></tr><tr><td>Female</td><td>1.00</td></tr><tr><td>Male</td><td>3.97 (1.17 - 13.42)</td></tr><tr><td>Informal care-giving arrangement</td><td></td></tr><tr><td>Spousal care</td><td>1... | <table><tr><td>Model I*</td><td colspan="2">Model II**</td></tr><tr><td>P</td><td>HR (95% CI)</td><td>P</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td>1.00</td><td></td></tr><tr><td>0.027</td><td>5.13 (2.25 - 11.69)</td><td>< 0.0001</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td>1.00</td><... |
2630867b7f64e6dac50abf5e2c9abd110e976cde8a349997c1e15e8c90d0f789.png | complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="2">Adjusting for age and gender</td><td colspan="2">Simple logistic regression</td><td colspan="2">Multiple logistic regression</td></tr><tr><td>OR (95% CI)</td><td><i>P</i></td><td>OR (95% CI)</td><td><i>P</i></td><td>OR (95% CI)</td><td><i>P</i></td></tr><tr... | <table><tr><td rowspan="2">Characteristics</td><td colspan="2">Adjusting for age and gender</td><td colspan="2">Simple logistic regression</td><td colspan="2">Multiple logistic regression</td></tr><tr><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td></tr><tr><td>Age (years)</td>... | <table><tr><td rowspan="2">Characteristics</td><td colspan="2">Adjusting for age and gender</td><td colspan="2">Simple logistic regression</td><td colspan="2">Multiple logistic regression</td></tr><tr><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td><td>OR (95% CI)</td><td>P</td></tr><tr><td>Adropin (ng/mL)<... |
01fd7e09849dabdc6113ec8f9276a113e460d547d03b9d3bbd60a1dab0f7c6f9.png | simple | <table><tr><td>Condition</td><td>Femoral Taper Mean + Standard Deviation (Newtons)</td><td>Acetabular Taper Mean + Standard Deviation (Newtons)</td></tr><tr><td>10 million cycles dynamic fatigue</td><td>12,957 + 1797</td><td>3429 + 347</td></tr><tr><td>50 million cycles dynamic fatigue</td><td>12,506 + 774</td><td>4329... | <table><tr><td>Conditio</td><td>Femoral Taper Mean + Standard Deviatio</td><td>Acetabular Taper Mean + Standard </td></tr></table> | <table><tr><td>n</td><td>n (Newtons)</td><td>Deviation (Newtons)</td></tr><tr><td>10 million cycles dynamic fatigue</td><td>12,957 + 1797</td><td>3429 + 347</td></tr><tr><td>50 million cycles dynamic fatigue</td><td>12,506 + 774</td><td>4329 + 443</td></tr></table> |
8ddcc77ba88032929425220e5e17ce2cd6b893cfb73da6861c4528eec6516cf2.png | simple | <table><tr><td>Characteristics</td><td>No of patients</td><td>%</td><td>TIMP-1 negativeN (%)</td><td>TIMP-1 positiveN (%)</td><td><i>P</i></td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td>0.34</td></tr><tr><td> <50</td><td>47</td><td>28.8</td><td>44 (93.6)</td><td>3 (6.4)</td><td></td></tr><tr><td> 5... | <table><tr><td>Characteristics</td><td>No of patients</td><td>%</td><td>TIMP-1 negativeN (%)</td><td>TIMP-1 positiveN (%)</td><td>P</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td>0.34</td></tr><tr><td><50</td><td>47</td><td>28.8</td><td>44 (93.6)</td><td>3 (6.4)</td><td></td></tr><tr><td>51-65</td><td... | <table><tr><td>Characteristics</td><td>No of patients</td><td>%</td><td>TIMP-1 negativeN (%)</td><td>TIMP-1 positiveN (%)</td><td>P</td></tr><tr><td>Clear cell</td><td>5</td><td>3.1</td><td>4 (80.0)</td><td>1 (20.0)</td><td></td></tr><tr><td>Mucinous</td><td>9</td><td>5.5</td><td>4 (44.4)</td><td>5 (55.6)</td><td></td>... |
83d223617f2797acd509f3399e7ae0ac75efb00cf95e427230d826b924df0584.png | complex | <table><tr><td></td><td colspan="3">Lctg (<i>n</i> = 7)</td><td colspan="3">Fccg (<i>n</i> = 9)</td></tr><tr><td></td><td>Pre</td><td>Post</td><td>Difference</td><td>Pre</td><td>Post</td><td>Difference</td></tr><tr><td colspan="7">ONE LEG PRESS (1 RM<sup>*</sup> IN kg)</td></tr><tr><td>Right</td><td>151 ± 31</td><... | <table><tr><td></td><td colspan="3">Lctg (n = 7)</td><td colspan="3">Fccg (n = 9)</td></tr><tr><td></td><td>Pre</td><td>Post</td><td>Difference</td><td>Pre</td><td>Post</td><td>Difference</td></tr></table> | <table><tr><td colspan="7">ONE LEG PRESS (1 RM* IN kg)</td></tr><tr><td>Right</td><td>151 ± 31</td><td>152 ± 34</td><td>1 ± 4</td><td>128 ± 14</td><td>130 ± 18</td><td>2 ± 8</td></tr><tr><td>Left</td><td>150 ± 38</td><td>148 ± 37</td><td>−1 ± 5</td><td>122 ± 12</td><td>123 ± 14</td><td>1 ± 7</td></tr><tr><td colspan="7... |
2ff4d9353dee0d3549f9dde2fdc7b3f19340f451fcb35b986f969747d159ac6b.png | simple | <table><tr><td>Specimen No.</td><td>Tensile Strength (MPa)</td><td>Modulus of Elasticity (GPa)</td><td>Strain to Failure (%)</td></tr><tr><td>1</td><td>42.65</td><td>0.68</td><td>6.27</td></tr><tr><td>2</td><td>38.24</td><td>0.67</td><td>5.71</td></tr><tr><td>3</td><td>48.04</td><td>0.68</td><td>7.11</td></tr><tr><td>4... | <table><tr><td>Specimen No.</td><td>Tensile Strength (MPa)</td><td>Modulus of Elasticity (GPa)</td><td>Strain to Failure (%)</td></tr><tr><td>1</td><td>42.65</td><td>0.68</td><td>6.27</td></tr><tr><td>2</td><td>38.24</td><td>0.67</td><td>5.71</td></tr><tr><td>3</td><td>48.04</td><td>0.68</td><td>7.11</td></tr><tr><td>4... | <table><tr><td>Specimen No.</td><td>Tensile Strength (MPa)</td><td>Modulus of Elasticity (GPa)</td><td>Strain to Failure (%)</td></tr><tr><td></td><td>45.70</td><td>71</td><td>.40</td></tr><tr><td>8</td><td>37.39</td><td>0.65</td><td>5.78</td></tr><tr><td>9</td><td>39.20</td><td>0.73</td><td>5.37</td></tr><tr><td>10</t... |
1c303682b5354605ed2646a678205ff295c01d38fa9de178801fc8549b8ef1c4.png | simple | <table><tr><td>Genotype</td><td>α<sup>+</sup>/β<sup>+</sup>/γ<sup>+</sup></td><td>α<sup>−</sup>/β<sup>+</sup>/γ<sup>+</sup></td><td>α<sup>+</sup>/β<sup>−</sup>/γ<sup>+</sup></td><td>α<sup>+</sup>/β<sup>+</sup>/γ<sup>−</sup></td><td>α<sup... | <table><tr><td>Genotype</td><td>α+/β+/γ+</td><td>α−/β+/γ+</td><td>α+/β−/γ+</td></tr><tr><td>DOPAC:DA</td><td></td><td></td><td></td></tr><tr><td>Average</td><td>0.1019</td><td>0.1044</td><td>0.0940</td></tr><tr><td>SEM</td><td>0.0062</td><td>0.0046</td><td>0.0047</td></tr><tr><td>HVA:DA</td><td></td><td></td><td></td><... | <table><tr><td>α+/β+/γ−</td><td>α−/β+/γ−</td><td>α+/β−/γ−</td><td>α−/β−/γ+</td><td>α−/β−/γ−</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0.0981</td><td>0.1150</td><td>0.0893</td><td>0.0807∗</td><td>0.1608∗∗</td></tr><tr><td>0.0072</td><td>0.0043</td><td>0.0051</td><td>0.0053</td><td>0.0091</td... |
fa6f4c5ed3cb7f522a01893772a420b9a7574c8ecb0a0cd8b080eb9189313f3a.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">All PTB cases</td><td colspan="2">PTB cases with smear results<sup>a</sup></td><td colspan="2">PTB cases without smear results<sup>a</sup></td><td></td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td><i>p</i> value</td></tr><tr><td>Age, y... | <table><tr><td rowspan="2">Variables</td></tr><tr></tr><tr><td>Age, years, mean (SD)</td></tr><tr><td>Gender</td></tr><tr><td>Female</td></tr><tr><td>Male</td></tr><tr><td>HIV status</td></tr><tr><td>Negative</td></tr><tr><td>Positive</td></tr><tr><td>Unknown</td></tr><tr><td>Disease classification</td></tr><tr><td>PTB... | <table><tr><td colspan="2">All PTB cases</td><td colspan="2">PTB cases with smear resultsa</td><td colspan="2">PTB cases without smear resultsa</td><td></td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>p value</td></tr><tr><td>36 ± 12.8</td><td>-</td><td>35 ± 13.1</td><td>-</td><td>37 ± 12.3... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.